JPH1124193A - Silver halide photographic sensitive material - Google Patents
Silver halide photographic sensitive materialInfo
- Publication number
- JPH1124193A JPH1124193A JP17828297A JP17828297A JPH1124193A JP H1124193 A JPH1124193 A JP H1124193A JP 17828297 A JP17828297 A JP 17828297A JP 17828297 A JP17828297 A JP 17828297A JP H1124193 A JPH1124193 A JP H1124193A
- Authority
- JP
- Japan
- Prior art keywords
- group
- silver halide
- compound
- solution
- photographic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 Silver halide Chemical class 0.000 title claims abstract description 101
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 58
- 239000004332 silver Substances 0.000 title claims abstract description 58
- 239000000463 material Substances 0.000 title claims abstract description 50
- 150000001875 compounds Chemical class 0.000 claims abstract description 88
- 239000000839 emulsion Substances 0.000 claims abstract description 26
- 229920000642 polymer Polymers 0.000 claims abstract description 21
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 13
- 239000001045 blue dye Substances 0.000 claims abstract description 5
- 239000000084 colloidal system Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 15
- 238000011161 development Methods 0.000 abstract description 15
- 239000000975 dye Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 5
- 238000003860 storage Methods 0.000 abstract description 5
- 239000003638 chemical reducing agent Substances 0.000 abstract description 3
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 230000000873 masking effect Effects 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 62
- 239000003094 microcapsule Substances 0.000 description 33
- 239000010410 layer Substances 0.000 description 30
- 238000000034 method Methods 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 108010010803 Gelatin Proteins 0.000 description 18
- 239000008273 gelatin Substances 0.000 description 18
- 229920000159 gelatin Polymers 0.000 description 18
- 235000019322 gelatine Nutrition 0.000 description 18
- 235000011852 gelatine desserts Nutrition 0.000 description 18
- 238000012545 processing Methods 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 13
- 206010070834 Sensitisation Diseases 0.000 description 12
- 125000003118 aryl group Chemical group 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 12
- 230000008313 sensitization Effects 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 230000001235 sensitizing effect Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 229910052711 selenium Inorganic materials 0.000 description 8
- 239000011669 selenium Substances 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 230000005070 ripening Effects 0.000 description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 6
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 5
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 239000011162 core material Substances 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 241000872198 Serjania polyphylla Species 0.000 description 4
- 229910021612 Silver iodide Inorganic materials 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229940045105 silver iodide Drugs 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 229940065287 selenium compound Drugs 0.000 description 3
- 150000003343 selenium compounds Chemical class 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 125000000542 sulfonic acid group Chemical group 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- KGYLMXMMQNTWEM-UHFFFAOYSA-J tetrachloropalladium Chemical compound Cl[Pd](Cl)(Cl)Cl KGYLMXMMQNTWEM-UHFFFAOYSA-J 0.000 description 3
- ZFVJLNKVUKIPPI-UHFFFAOYSA-N triphenyl(selanylidene)-$l^{5}-phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=[Se])C1=CC=CC=C1 ZFVJLNKVUKIPPI-UHFFFAOYSA-N 0.000 description 3
- AXCGIKGRPLMUDF-UHFFFAOYSA-N 2,6-dichloro-1h-1,3,5-triazin-4-one;sodium Chemical compound [Na].OC1=NC(Cl)=NC(Cl)=N1 AXCGIKGRPLMUDF-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- ZUIVNYGZFPOXFW-UHFFFAOYSA-N chembl1717603 Chemical compound N1=C(C)C=C(O)N2N=CN=C21 ZUIVNYGZFPOXFW-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 2
- 229940116357 potassium thiocyanate Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229910052714 tellurium Inorganic materials 0.000 description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
- LXEJRKJRKIFVNY-UHFFFAOYSA-N terephthaloyl chloride Chemical compound ClC(=O)C1=CC=C(C(Cl)=O)C=C1 LXEJRKJRKIFVNY-UHFFFAOYSA-N 0.000 description 2
- XGMYMWYPSYIPQB-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethoxy)butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC(C([O-])=O)OC(C([O-])=O)CC([O-])=O XGMYMWYPSYIPQB-UHFFFAOYSA-J 0.000 description 2
- 150000003536 tetrazoles Chemical class 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- WFNHDWNSTLRUOC-UHFFFAOYSA-M (2-nitrophenyl)-triphenylphosphanium;chloride Chemical compound [Cl-].[O-][N+](=O)C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WFNHDWNSTLRUOC-UHFFFAOYSA-M 0.000 description 1
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 1
- OMAWWKIPXLIPDE-UHFFFAOYSA-N (ethyldiselanyl)ethane Chemical compound CC[Se][Se]CC OMAWWKIPXLIPDE-UHFFFAOYSA-N 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- RVXJIYJPQXRIEM-UHFFFAOYSA-N 1-$l^{1}-selanyl-n,n-dimethylmethanimidamide Chemical compound CN(C)C([Se])=N RVXJIYJPQXRIEM-UHFFFAOYSA-N 0.000 description 1
- FXEIVSYQEOJLBU-UHFFFAOYSA-N 1-$l^{1}-selanylethanimine Chemical compound CC([Se])=N FXEIVSYQEOJLBU-UHFFFAOYSA-N 0.000 description 1
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- RWRRHLLCHRNBFY-UHFFFAOYSA-N 1-[1-(dimethylamino)ethyl]-2h-tetrazole-5-thione Chemical compound CN(C)C(C)N1N=NN=C1S RWRRHLLCHRNBFY-UHFFFAOYSA-N 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- JHKKTXXMAQLGJB-UHFFFAOYSA-N 2-(methylamino)phenol Chemical compound CNC1=CC=CC=C1O JHKKTXXMAQLGJB-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- JIGUICYYOYEXFS-UHFFFAOYSA-N 3-tert-butylbenzene-1,2-diol Chemical compound CC(C)(C)C1=CC=CC(O)=C1O JIGUICYYOYEXFS-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- IAAUBYJFFBMQHB-UHFFFAOYSA-N CCNC(=[Se])N(CC)CC Chemical compound CCNC(=[Se])N(CC)CC IAAUBYJFFBMQHB-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 238000001016 Ostwald ripening Methods 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical group C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- HOLVRJRSWZOAJU-UHFFFAOYSA-N [Ag].ICl Chemical compound [Ag].ICl HOLVRJRSWZOAJU-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- PWAXUOGZOSVGBO-UHFFFAOYSA-N adipoyl chloride Chemical compound ClC(=O)CCCCC(Cl)=O PWAXUOGZOSVGBO-UHFFFAOYSA-N 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- NXIXYAIYSSMLJK-UHFFFAOYSA-N azanium;3,4-dihydroxybenzenesulfonate Chemical compound N.OC1=CC=C(S(O)(=O)=O)C=C1O NXIXYAIYSSMLJK-UHFFFAOYSA-N 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- YOUGRGFIHBUKRS-UHFFFAOYSA-N benzyl(trimethyl)azanium Chemical compound C[N+](C)(C)CC1=CC=CC=C1 YOUGRGFIHBUKRS-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 150000001661 cadmium Chemical class 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- GTKRFUAGOKINCA-UHFFFAOYSA-M chlorosilver;silver Chemical class [Ag].[Ag]Cl GTKRFUAGOKINCA-UHFFFAOYSA-M 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- WMPOZLHMGVKUEJ-UHFFFAOYSA-N decanedioyl dichloride Chemical compound ClC(=O)CCCCCCCCC(Cl)=O WMPOZLHMGVKUEJ-UHFFFAOYSA-N 0.000 description 1
- 150000005205 dihydroxybenzenes Chemical class 0.000 description 1
- OWMBTIRJFMGPAC-UHFFFAOYSA-N dimethylamino 2-methylprop-2-enoate Chemical compound CN(C)OC(=O)C(C)=C OWMBTIRJFMGPAC-UHFFFAOYSA-N 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KWKXNDCHNDYVRT-UHFFFAOYSA-N dodecylbenzene Chemical compound CCCCCCCCCCCCC1=CC=CC=C1 KWKXNDCHNDYVRT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- ALCDAWARCQFJBA-UHFFFAOYSA-N ethylselanylethane Chemical compound CC[Se]CC ALCDAWARCQFJBA-UHFFFAOYSA-N 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- PBZROIMXDZTJDF-UHFFFAOYSA-N hepta-1,6-dien-4-one Chemical compound C=CCC(=O)CC=C PBZROIMXDZTJDF-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002503 iridium Chemical class 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- BITXABIVVURDNX-UHFFFAOYSA-N isoselenocyanic acid Chemical class N=C=[Se] BITXABIVVURDNX-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 229920003146 methacrylic ester copolymer Polymers 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- SSZIHNPJCQNODF-UHFFFAOYSA-N n,n-dimethylbenzenecarboselenoamide Chemical compound CN(C)C(=[Se])C1=CC=CC=C1 SSZIHNPJCQNODF-UHFFFAOYSA-N 0.000 description 1
- RODAXCQJQDMNSH-UHFFFAOYSA-N n-[4-(diethylamino)-6-(hydroxyamino)-1,3,5-triazin-2-yl]hydroxylamine Chemical compound CCN(CC)C1=NC(NO)=NC(NO)=N1 RODAXCQJQDMNSH-UHFFFAOYSA-N 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004708 n-butylthio group Chemical group C(CCC)S* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002907 osmium Chemical class 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000005544 phthalimido group Chemical group 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011970 polystyrene sulfonate Substances 0.000 description 1
- 229960002796 polystyrene sulfonate Drugs 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GNHOJBNSNUXZQA-UHFFFAOYSA-J potassium aluminium sulfate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GNHOJBNSNUXZQA-UHFFFAOYSA-J 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 238000007761 roller coating Methods 0.000 description 1
- 150000003303 ruthenium Chemical class 0.000 description 1
- 150000003346 selenoethers Chemical class 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 1
- MSFPLIAKTHOCQP-UHFFFAOYSA-M silver iodide Chemical compound I[Ag] MSFPLIAKTHOCQP-UHFFFAOYSA-M 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- HPBLIKPMIWOUBQ-UHFFFAOYSA-M sodium;1,3,4-tri(propan-2-yl)naphthalene-2-sulfonate Chemical compound [Na+].C1=CC=C2C(C(C)C)=C(S([O-])(=O)=O)C(C(C)C)=C(C(C)C)C2=C1 HPBLIKPMIWOUBQ-UHFFFAOYSA-M 0.000 description 1
- AMZPPWFHMNMIEI-UHFFFAOYSA-M sodium;2-sulfanylidene-1,3-dihydrobenzimidazole-5-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=C2NC(=S)NC2=C1 AMZPPWFHMNMIEI-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 150000003498 tellurium compounds Chemical class 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 150000003475 thallium Chemical class 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Substances CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- FUSUHKVFWTUUBE-UHFFFAOYSA-N vinyl methyl ketone Natural products CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、ハロゲン化銀写真
感光材料に関し、特に安定性、保存性に優れたハロゲン
化銀写真感光材料に関するものである。The present invention relates to a silver halide photographic light-sensitive material, and more particularly to a silver halide photographic light-sensitive material having excellent stability and storage stability.
【0002】[0002]
【従来の技術】ハロゲン化銀写真感光材料には、その構
成上、性能向上等から種々の写真有用化合物が添加され
ている。2. Description of the Related Art Various photographic useful compounds have been added to silver halide photographic light-sensitive materials in view of their constitution and performance.
【0003】従来、写真有用化合物(写真添加剤)の調
液時、感光材料塗布液の調液時、塗布後の乾燥時、ま
た、感光材料の保存時などにおいて、写真有用化合物が
他の化合物の影響を受け、本来の機能が阻害されるなど
の問題があった。Conventionally, when preparing a photographic useful compound (photographic additive), preparing a photographic material coating solution, drying after coating, or storing a photographic material, the photographic useful compound is replaced with another compound. And the original function is hindered.
【0004】例えば、特開平3−153234号等に記
載されている現像主薬の酸化体と反応して青色色素を形
成するロイコ化合物でも、現像時以外、例えば塗布液調
液時やフィルム保存時で、発色してしまい、目的とする
イメージワイズな銀色調改良性能(低濃度部では青色濃
度が低く、中から高濃度部で青色濃度が高い)が十分得
られないという問題があった。For example, a leuco compound described in JP-A-3-153234, which reacts with an oxidized form of a developing agent to form a blue dye, can be used at times other than development, for example, at the time of preparing a coating solution or storing a film. In addition, there is a problem in that the desired color tone improving performance (low blue density is low in the low density area and high blue density is high in the middle to high density area) is not sufficiently obtained.
【0005】[0005]
【発明が解決しようとする課題】したがって、本発明の
目的は、安定性、保存性に優れたハロゲン化銀写真感光
材料を提供することである。SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a silver halide photographic material having excellent stability and storage stability.
【0006】[0006]
【課題を解決するための手段】本発明の上記目的は下記
構成により達成された。The above object of the present invention has been attained by the following constitutions.
【0007】(1).支持体上に、少なくとも1層のハ
ロゲン化銀乳剤層を含む親水性コロイド層を設けたハロ
ゲン化銀写真感光材料において、前記親水性コロイド層
が、ポリマーによってマイクロカプセル化した写真有用
化合物を含有することを特徴とするハロゲン化銀写真感
光材料。(1). In a silver halide photographic material provided with a hydrophilic colloid layer including at least one silver halide emulsion layer on a support, the hydrophilic colloid layer contains a photographically useful compound microencapsulated by a polymer. A silver halide photographic light-sensitive material, characterized in that:
【0008】(2).前記ポリマーが、アルカリ可溶性
のポリマーであることを特徴とする(1)記載のハロゲ
ン化銀写真感光材料。(2). The silver halide photographic material according to (1), wherein the polymer is an alkali-soluble polymer.
【0009】(3).前記ポリマーが、pH=6以上で
可溶であることを特徴とする(1)または(2)記載の
ハロゲン化銀写真感光材料。(3). The silver halide photographic material according to (1) or (2), wherein the polymer is soluble at pH = 6 or more.
【0010】(4).前記写真有用化合物が、現像主薬
の酸化体と反応して青色色素を形成するロイコ化合物で
あることを特徴とする(1)〜(3)のいずれか1項記
載のハロゲン化銀写真感光材料。(4). The silver halide photographic light-sensitive material according to any one of (1) to (3), wherein the photographically useful compound is a leuco compound which forms a blue dye by reacting with an oxidized form of a developing agent.
【0011】以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
【0012】本発明における写真有用化合物とは、例え
ば、写真カプラー(イエロー,マゼンタおよびシアン画
像形成カプラー、カラードもしくはマスキングカプラ
ー、抑制剤放出型カプラーおよび漂白促進剤放出型カプ
ラー、色素放出型カプラー等を含む)、UV吸収剤、還
元剤、現像主薬、現像増強剤などが含まれる。The photographically useful compound in the present invention includes, for example, photographic couplers (yellow, magenta and cyan image forming couplers, colored or masking couplers, inhibitor releasing couplers and bleaching accelerator releasing couplers, dye releasing couplers and the like). ), UV absorbers, reducing agents, developing agents, development enhancers, and the like.
【0013】本発明の写真有用化合物の中で、マイクロ
カプセル化の効果が特に大きいものとして、現像主薬の
酸化体と反応して、青色色素を形成するロイコ化合物が
挙げられ、好ましいものとして、現像主薬の酸化体と反
応して、青色色素を形成する下記の一般式(1)〜
(4)で表されるロイコ化合物(以下、本発明の一般式
(1)〜(4)で表されるロイコ化合物、または本発明
の一般式(1)〜(4)のロイコ化合物ともいう)が挙
げられる。Among the photographically useful compounds of the present invention, a leuco compound which forms a blue dye by reacting with an oxidized form of a developing agent is particularly effective for microencapsulation. The following general formulas (1) to form a blue pigment by reacting with the oxidized form of the base drug
Leuco compound represented by (4) (hereinafter also referred to as leuco compound represented by general formulas (1) to (4) of the present invention, or leuco compound represented by general formulas (1) to (4) of the present invention) Is mentioned.
【0014】以下、本発明の一般式(1)〜(4)で表
されるロイコ化合物について説明する。Hereinafter, the leuco compounds represented by formulas (1) to (4) of the present invention will be described.
【0015】[0015]
【化1】 Embedded image
【0016】〔〔式中、Wは−NR1R2、−OHまたは
−OZを表し、R1およびR2はそれぞれアルキル基また
はアリール基を表し、Zはアルカリ金属イオンまたは第
四級アンモニウムイオンを表す。R3は水素原子、ハロ
ゲン原子または1価の置換基を表し、nは1〜3の整数
を表す。Z1およびZ2はそれぞれ窒素原子または=C
(R3)−を表す。XはZ1、Z2およびそれに隣接する
炭素原子とともに5〜6員の芳香族ヘテロ環を構築する
のに必要な原子群を表す。R4は水素原子、アシル基、
スルホニル基、カルバモイル基、スルホ基、スルファモ
イル基、アルコキシカルボニル基またはアリールオキシ
カルボニル基を表す。Rは脂肪族基又は芳香族基を表
す。pは0〜2の整数を表す。CP1は以下の基を表
す。〕[Wherein, W represents -NR 1 R 2 , -OH or -OZ, R 1 and R 2 each represent an alkyl group or an aryl group, and Z represents an alkali metal ion or a quaternary ammonium ion. Represents R 3 represents a hydrogen atom, a halogen atom or a monovalent substituent, and n represents an integer of 1 to 3. Z 1 and Z 2 are each a nitrogen atom or CC
(R 3 ) —. X represents an atomic group necessary for constructing a 5- to 6-membered aromatic heterocyclic ring together with Z 1 , Z 2 and carbon atoms adjacent thereto. R 4 is a hydrogen atom, an acyl group,
Represents a sulfonyl group, a carbamoyl group, a sulfo group, a sulfamoyl group, an alkoxycarbonyl group or an aryloxycarbonyl group. R represents an aliphatic group or an aromatic group. p represents an integer of 0 to 2. CP1 represents the following groups. ]
【0017】[0017]
【化2】 Embedded image
【0018】[0018]
【化3】 Embedded image
【0019】〔式中、R5〜R8はそれぞれ水素原子、ハ
ロゲン原子およびベンゼン環に置換可能な置換基を表
す。またR5とR6及びR7とR8は互いに結合して5〜7
員の環を形成しても良い。R9はR4と同義である。R10
およびR11はそれぞれアルキル基、アリール基またはヘ
テロ環基を表す。R12はR4と同義である。R13および
R14はR10およびR11と同義である。R15はR12と同義
である。R16はアルキル基、アリール基、スルホニル
基、トリフルオロメチル基、カルボキシ基、アリールオ
キシカルボニル基、アルコキシカルボニル基、カルバモ
イル基またはシアノ基を表す。R17はR4と同義であ
る。R18はR3と同義であり、mは1〜3の整数を表
す。Y1は2つの窒素原子とともに5及び6員の単環ま
たは縮合環の含窒素ヘテロ環を構築するのに必要な原子
群を表す。R19およびR20はアルキル基又はアリール基
を表す。R21はR4と同義である。R22およびR23はR
19およびR20と同義である。R24はR21と同義である。
R25、R27およびR28は水素原子または置換基を表す。
R26はR4と同義である。R29、R31およびR32は
R25、R27およびR28と同義である。R30はR26と同義
である。R34、R35およびR36はR25、R27およびR28
と同義である。R33はR26と同義である。R38、R39お
よびR40はR25、R27およびR28と同義である。R37は
R26と同義である。R41、R42およびR43はR25、R27
およびR28と同義である。R44はR26と同義である。★
は一般式(1)におけるCP1と他の部分構造との結合
点を表す。〕〕 前記一般式(1)で表される化合物は、さらに下記一般
式(2)で表される化合物であることが好ましい。[Wherein, R 5 to R 8 each represent a hydrogen atom, a halogen atom or a substituent capable of substituting on a benzene ring. R 5 and R 6 and R 7 and R 8 are bonded to each other to form 5 to 7;
A member ring may be formed. R 9 has the same meaning as R 4 . R 10
And R 11 each represents an alkyl group, an aryl group or a heterocyclic group. R 12 has the same meaning as R 4 . R 13 and R 14 have the same meaning as R 10 and R 11 . R 15 has the same meaning as R 12 . R 16 represents an alkyl group, an aryl group, a sulfonyl group, a trifluoromethyl group, a carboxy group, an aryloxycarbonyl group, an alkoxycarbonyl group, a carbamoyl group or a cyano group. R 17 has the same meaning as R 4 . R 18 has the same meaning as R 3 , and m represents an integer of 1 to 3. Y1 represents an atomic group necessary for constructing a 5- or 6-membered monocyclic or condensed nitrogen-containing heterocyclic ring together with two nitrogen atoms. R 19 and R 20 represent an alkyl group or an aryl group. R 21 has the same meaning as R 4 . R 22 and R 23 are R
It is synonymous with 19 and R 20. R 24 has the same meaning as R 21 .
R 25 , R 27 and R 28 represent a hydrogen atom or a substituent.
R 26 has the same meaning as R 4 . R 29 , R 31 and R 32 have the same meanings as R 25 , R 27 and R 28 . R 30 has the same meaning as R 26 . R 34 , R 35 and R 36 are R 25 , R 27 and R 28
Is synonymous with R 33 has the same meaning as R 26 . R 38 , R 39 and R 40 have the same meaning as R 25 , R 27 and R 28 . R 37 has the same meaning as R 26 . R 41 , R 42 and R 43 are R 25 , R 27
And R 28 have the same meanings. R 44 has the same meaning as R 26 . ★
Represents a bonding point between CP1 and another partial structure in the general formula (1). ]] It is preferable that the compound represented by the general formula (1) is a compound represented by the following general formula (2).
【0020】[0020]
【化4】 Embedded image
【0021】〔式中、R1、R2、R3、R4、CP1、
n、Rおよびpは一般式(1)におけるR1、R2、
R3、R4、CP1、n、Rおよびpと同義である。〕 更に本発明では、下記一般式(3)で表される化合物も
好ましく用いられるが、この場合、RSO3Hで表され
る化合物の少なくとも1種を含有することが好ましく、
更に好ましくはRSO3Hで表される化合物が、一般式
(3)で表される化合物と同じ層に含有されることであ
る。[Wherein R 1 , R 2 , R 3 , R 4 , CP 1,
n, R and p are R 1 , R 2 ,
It has the same meaning as R 3 , R 4 , CP 1, n, R and p. Further, in the present invention, a compound represented by the following general formula (3) is also preferably used. In this case, the compound preferably contains at least one kind of a compound represented by RSO 3 H,
More preferably, the compound represented by RSO 3 H is contained in the same layer as the compound represented by the general formula (3).
【0022】[0022]
【化5】 Embedded image
【0023】〔式中、R3、n、R4、W、X、Z1、
Z2、およびCP1は一般式(1)におけるR3、n、R
4、W、X、Z1、Z2、およびCP1と同義である。〕 前記一般式(3)で表される化合物は更に下記一般式
(4)で表される化合物であることが好ましい。Wherein R 3 , n, R 4 , W, X, Z 1 ,
Z 2 and CP1 represent R 3 , n, R in the general formula (1).
4 , synonymous with W, X, Z 1 , Z 2 and CP1. The compound represented by the general formula (3) is preferably a compound represented by the following general formula (4).
【0024】[0024]
【化6】 Embedded image
【0025】〔式中、R1、R2、R3、R4、CP1およ
びnは一般式(1)におけるR1、R2、R3、R4、CP
1およびnと同義である。〕 尚、前記一般式(1)〜(4)で表されるロイコ化合物
においてR4、R9、R12、R15、R17、R21、R24、R
26、R30、R33、R37およびR44で表される基の少なく
とも1つが、−COOM1および−SO3M2(M1及びM
2はそれぞれ水素原子又はアルカリ金属を表す)から選
ばれる少なくとも1つで置換されていてもよい。[Wherein R 1 , R 2 , R 3 , R 4 , CP 1 and n represent R 1 , R 2 , R 3 , R 4 , CP in the general formula (1).
Synonymous with 1 and n. In the leuco compounds represented by the general formulas (1) to (4), R 4 , R 9 , R 12 , R 15 , R 17 , R 21 , R 24 , R
At least one of the groups represented by 26 , R 30 , R 33 , R 37 and R 44 is —COOM 1 and —SO 3 M 2 (M 1 and M
2 each represents a hydrogen atom or an alkali metal).
【0026】以下、一般式(1)〜(4)で表されるロ
イコ化合物について詳細に説明する。Hereinafter, the leuco compounds represented by the general formulas (1) to (4) will be described in detail.
【0027】一般式(1)〜(4)において、R1及び
R2で表されるアルキル基としては、好ましくはメチル
基、エチル基、プロピル基、ブチル基等が挙げられる。
これらはさらに置換されていてもよく好ましい置換基と
してヒドロキシ基、スルホンアミド基が挙げられる。In the general formulas (1) to (4), the alkyl group represented by R 1 and R 2 preferably includes a methyl group, an ethyl group, a propyl group and a butyl group.
These may be further substituted, and preferred substituents include a hydroxy group and a sulfonamide group.
【0028】R1及びR2で表されるアリール基として好
ましくはフェニル基が挙げられる。The aryl group represented by R 1 and R 2 is preferably a phenyl group.
【0029】R3で挙げられる1価の置換基としてはア
ルキル基(例えばメチル基、エチル基、イソプロピル
基、ヒドロキシエチル基、メトキシメチル基、トリフル
オロメチル基、t−ブチル基等)、シクロアルキル基
(例えばシクロペンチル基、シクロヘキシル基等)、ア
ラルキル基(例えばベンジル基、2−フェネチル基
等)、アリール基(例えばフェニル基、ナフチル基、p
−トリル基、p−クロロフェニル基等)、アルコキシル
基(例えばメトキシ基、エトキシ基、イソプロポキシ
基、n−ブトキシ基等)、アリールオキシ基(例えばフ
ェノキシ基等)、シアノ基、アシルアミノ基(例えばア
セチルアミノ基、プロピオニルアミノ基等)、アルキル
チオ基(例えばメチルチオ基、エチルチオ基、n−ブチ
ルチオ基等)、アリールチオ基(例えばフェニルチオ基
等)、スルホニルアミノ基(例えばメタンスルホニルア
ミノ基、ベンゼンスルホニルアミノ基等)、ウレイド基
(例えば3−メチルウレイド基、3,3−ジメチルウレ
イド基、1,3−ジメチルウレイド基等)、スルファモ
イルアミノ基(ジメチルスルファモイルアミノ基等)、
カルバモイル基(例えばメチルカルバモイル基、エチル
カルバモイル基、ジメチルカルバモイル基等)、スルフ
ァモイル基(例えばエチルスルファモイル基、ジメチル
スルファモイル基等)、アルコキシカルボニル基(例え
ばメトキシカルボニル基、エトキシカルボニル基等)、
アリールオキシカルボニル基(例えばフェノキシカルボ
ニル基等)、スルホニル基(例えばメタンスルホニル
基、ブタンスルホニル基、フェニルスルホニル基等)、
アシル基(例えばアセチル基、プロパノイル基、ブチロ
イル基等)、アミノ基(メチルアミノ基、エチルアミノ
基、ジメチルアミノ基等)、ヒドロキシ基、ニトロ基、
イミド基(例えばフタルイミド基等)、ヘテロ環基(例
えば、ピリジル基、ベンズイミダゾリル基、ベンズチア
ゾリル基、ベンズオキサゾリル基等)が挙げられる。Examples of the monovalent substituent represented by R 3 include an alkyl group (for example, a methyl group, an ethyl group, an isopropyl group, a hydroxyethyl group, a methoxymethyl group, a trifluoromethyl group, a t-butyl group, etc.), a cycloalkyl group and the like. Group (eg, cyclopentyl group, cyclohexyl group, etc.), aralkyl group (eg, benzyl group, 2-phenethyl group, etc.), aryl group (eg, phenyl group, naphthyl group, p
-Tolyl group, p-chlorophenyl group, etc.), alkoxyl group (eg, methoxy group, ethoxy group, isopropoxy group, n-butoxy group, etc.), aryloxy group (eg, phenoxy group, etc.), cyano group, acylamino group (eg, acetyl group) Amino group, propionylamino group, etc., alkylthio group (eg, methylthio group, ethylthio group, n-butylthio group, etc.), arylthio group (eg, phenylthio group, etc.), sulfonylamino group (eg, methanesulfonylamino group, benzenesulfonylamino group, etc.) ), Ureido groups (eg, 3-methylureido group, 3,3-dimethylureido group, 1,3-dimethylureido group, etc.), sulfamoylamino groups (dimethylsulfamoylamino group, etc.),
Carbamoyl group (eg, methylcarbamoyl group, ethylcarbamoyl group, dimethylcarbamoyl group, etc.), sulfamoyl group (eg, ethylsulfamoyl group, dimethylsulfamoyl group, etc.), alkoxycarbonyl group (eg, methoxycarbonyl group, ethoxycarbonyl group, etc.) ,
Aryloxycarbonyl group (for example, phenoxycarbonyl group, etc.), sulfonyl group (for example, methanesulfonyl group, butanesulfonyl group, phenylsulfonyl group, etc.),
Acyl group (for example, acetyl group, propanoyl group, butyroyl group, etc.), amino group (methylamino group, ethylamino group, dimethylamino group, etc.), hydroxy group, nitro group,
Examples include an imide group (for example, a phthalimido group) and a heterocyclic group (for example, a pyridyl group, a benzimidazolyl group, a benzothiazolyl group, a benzoxazolyl group, and the like).
【0030】R4で表されるアシル基として好ましく
は、アセチル基、トリフルオロアセチル基、ベンゾイル
基等が挙げられる。スルホニル基として好ましくは、メ
タンスルホニル基、ベンゼンスルホニル基等が挙げられ
る。カルバモイル基として好ましくは、ジエチルカルバ
モイル基、フェニルカルバモイル基等が挙げられる。ス
ルファモイル基として好ましくは、ジエチルスルファモ
イル基等が挙げられる。アルコキシカルボニル基として
好ましくは、メトキシカルボニルオキシ基、エトキシカ
ルボニルオキシ基が挙げられる。アリールオキシカルボ
ニル基として好ましくは、フェノキシカルボニルオキシ
基等が挙げられる。The acyl group represented by R 4 is preferably an acetyl group, a trifluoroacetyl group, a benzoyl group or the like. Preferred examples of the sulfonyl group include a methanesulfonyl group and a benzenesulfonyl group. Preferable examples of the carbamoyl group include a diethylcarbamoyl group and a phenylcarbamoyl group. Preferred examples of the sulfamoyl group include a diethylsulfamoyl group. The alkoxycarbonyl group preferably includes a methoxycarbonyloxy group and an ethoxycarbonyloxy group. Preferable examples of the aryloxycarbonyl group include a phenoxycarbonyloxy group.
【0031】Zで表されるアルカリ金属としてはナトリ
ウム、カリウム等が挙げられる。第四級アンモニウムと
しては、トリメチルベンジルアンモニウム、テトラブチ
ルアンモニウム、テトラデシルアンモニウム等の炭素総
数が8以上のアンモニウムが挙げられる。Examples of the alkali metal represented by Z include sodium and potassium. Examples of the quaternary ammonium include ammonium having a total carbon number of 8 or more, such as trimethylbenzylammonium, tetrabutylammonium, and tetradecylammonium.
【0032】X、Z1、Z2及びそれに隣接する炭素原子
で構築される5〜6員の芳香族ヘテロ環としてはピリジ
ン環、ピリミジン環、ピリダジン環、ピラジン環、トリ
アジン環、テトラジン環、ピロール環、フラン環、チオ
フェン環、チアゾール環、オキサゾール環、イミダゾー
ル環、チアジアゾール環、オキサジアゾール環等が挙げ
られる。好ましくはピリジン環である。Examples of the 5- or 6-membered aromatic hetero ring composed of X, Z 1 , Z 2 and carbon atoms adjacent thereto include a pyridine ring, a pyrimidine ring, a pyridazine ring, a pyrazine ring, a triazine ring, a tetrazine ring, and a pyrrole. Ring, furan ring, thiophene ring, thiazole ring, oxazole ring, imidazole ring, thiadiazole ring, oxadiazole ring and the like. Preferably it is a pyridine ring.
【0033】R5〜R8で表されるベンゼン環に置換可能
な置換基としては上述のR3で挙げられる1価の置換基
と同義の基を挙げることができる。好ましくはアルキル
基、アシルアミノ基である。Examples of the substituent capable of substituting on the benzene ring represented by R 5 to R 8 include groups having the same meaning as the above-mentioned monovalent substituent represented by R 3 . Preferred are an alkyl group and an acylamino group.
【0034】R5とR6及びR7とR8が互いに結合して形
成する5〜7員の環としては、芳香族炭素環及び複素環
が挙げられるが、好ましくはベンゼン環を挙げることが
できる。The 5- to 7-membered ring formed by combining R 5 and R 6 and R 7 and R 8 includes an aromatic carbon ring and a heterocyclic ring, preferably a benzene ring. it can.
【0035】R10及びR11で表されるアルキル基として
はメチル、エチル、プロピル、ブチル基等が挙げられ、
アリール基としてはフェニル基、ナフチル基等が挙げら
れ、ヘテロ環基としてはO、S、及びN原子の少なくと
も1種を環内に有する5〜6員の芳香族複素環(例え
ば、ピリジン、ピラジン、ピリミジン環等の6員環アジ
ン及びそのベンゼローグ:ピロール、チオフェン、フラ
ン及びそのベンゼローグ:イミダゾール、ピラゾール、
トリアゾール、テトラゾール、チアゾール、オキサゾー
ル、チアジアゾール、オキサジアゾール等の5員環アゾ
ール及びそのベンゼローグ等)が挙げられる。R10及び
R11として好ましくはフェニル基、ピラゾリル基、ピリ
ジル基等が挙げられる。Examples of the alkyl group represented by R 10 and R 11 include a methyl, ethyl, propyl and butyl group.
Examples of the aryl group include a phenyl group and a naphthyl group. Examples of the heterocyclic group include a 5- to 6-membered aromatic heterocycle having at least one of O, S, and N atoms in the ring (for example, pyridine, pyrazine , A 6-membered ring azine such as a pyrimidine ring and the like, and their benzerogues: pyrrole, thiophene, furan and their benzerogues: imidazole, pyrazole,
5-membered ring azoles such as triazole, tetrazole, thiazole, oxazole, thiadiazole, and oxadiazole, and benzerogue, etc.). R 10 and R 11 preferably include a phenyl group, a pyrazolyl group, a pyridyl group and the like.
【0036】R16で表されるアルキル基としてはメチル
基、イソプロピル基、ペンチル基、t−ブチル基等が挙
げられる。アリール基としてはフェニル基、ナフチル基
等が挙げられる。スルホニル基としてはメチンスルホニ
ル基、ベンゼンスルホニル基等が挙げられる。アリール
オキシカルボニル基としてはフェノキシカルボニル基等
が挙げられる。アルコキシカルボニル基としてはエトキ
シカルボニル基等が挙げられる。カルバモイル基として
はジエチルアミノカルバモイル基等が挙げられる。Examples of the alkyl group represented by R 16 include a methyl group, an isopropyl group, a pentyl group and a t-butyl group. Examples of the aryl group include a phenyl group and a naphthyl group. Examples of the sulfonyl group include a methine sulfonyl group and a benzenesulfonyl group. Examples of the aryloxycarbonyl group include a phenoxycarbonyl group. Examples of the alkoxycarbonyl group include an ethoxycarbonyl group. Examples of the carbamoyl group include a diethylaminocarbamoyl group.
【0037】Y1で表される含窒素ヘテロ環としてはイ
ミダゾール、トリアゾール、テトラゾール等の各環及び
そのベンゾ縮合環を挙げることができる。Examples of the nitrogen-containing heterocycle represented by Y1 include each of imidazole, triazole, tetrazole and the like, and benzo-fused rings thereof.
【0038】R19及びR20で表されるアルキル基として
はメチル基、ペンチル基、t−ブチル基等が挙げられ
る。アリール基としてフェニル基、ナフチル基等が挙げ
られる。Examples of the alkyl group represented by R 19 and R 20 include a methyl group, a pentyl group and a t-butyl group. Examples of the aryl group include a phenyl group and a naphthyl group.
【0039】R25、R27およびR28で表される置換基と
しては、フェニル基、メチル基、ベンゾイル基、フェノ
キシ基、エトキシ基等が挙げられる。Examples of the substituent represented by R 25 , R 27 and R 28 include a phenyl group, a methyl group, a benzoyl group, a phenoxy group and an ethoxy group.
【0040】Rで表される脂肪族基としては、ヘキシル
基、ドデシル基等が挙げられる。芳香族基としては、p
−トルエン、ドデシルベンゼン等が挙げられる。Examples of the aliphatic group represented by R include a hexyl group and a dodecyl group. As the aromatic group, p
-Toluene, dodecylbenzene and the like.
【0041】以下、一般式(1)〜(4)で表されるロ
イコ化合物を具体的に列挙するが、これらに限定される
ものではない。The leuco compounds represented by the general formulas (1) to (4) will be specifically described below, but the invention is not limited thereto.
【0042】[0042]
【化7】 Embedded image
【0043】[0043]
【化8】 Embedded image
【0044】[0044]
【化9】 Embedded image
【0045】[0045]
【化10】 Embedded image
【0046】[0046]
【化11】 Embedded image
【0047】[0047]
【化12】 Embedded image
【0048】[0048]
【化13】 Embedded image
【0049】[0049]
【化14】 Embedded image
【0050】[0050]
【化15】 Embedded image
【0051】[0051]
【化16】 Embedded image
【0052】[0052]
【化17】 Embedded image
【0053】[0053]
【化18】 Embedded image
【0054】合成例1(例示化合物8の合成) 反応経路Synthesis Example 1 (Synthesis of Exemplified Compound 8) Reaction Route
【0055】[0055]
【化19】 Embedded image
【0056】(1)3.9gを酢酸エチル50mlに溶
解し、5%Pd/C0.5gを加え常圧接触水素添加を
おこなった。反応液の青色が消失し、(2)が生成し
た。(1) 3.9 g was dissolved in 50 ml of ethyl acetate, 0.5 g of 5% Pd / C was added, and hydrogenation was carried out at normal pressure. The blue color of the reaction solution disappeared, and (2) was formed.
【0057】次に反応液にトリエチルアミン1.2g、
及びアセチルクロリド1.5gを加え室温で2時間撹拌
した。触媒及び不溶物を濾別し、残渣を酢酸エチルから
再結晶して目的の例示化合物8を3.8g(収率89
%)得た。Next, 1.2 g of triethylamine was added to the reaction solution.
And 1.5 g of acetyl chloride were added, and the mixture was stirred at room temperature for 2 hours. The catalyst and insolubles were separated by filtration, and the residue was recrystallized from ethyl acetate to give 3.8 g of the desired Exemplified Compound 8 (yield: 89).
%)Obtained.
【0058】構造はNMRスペクトル及びMassスペ
クトルにより確認した。The structure was confirmed by NMR spectrum and Mass spectrum.
【0059】合成例2(例示化合物9の合成) 反応経路Synthesis Example 2 (Synthesis of Exemplified Compound 9)
【0060】[0060]
【化20】 Embedded image
【0061】合成例1の(1)3.9gを酢酸エチル5
0mlに溶解し、5%Pd/C0.5gを加え常圧接触
水素添加をおこなった。反応液の青色が消失し、(2)
が生成した。3.9 g of (1) of Synthesis Example 1 was treated with ethyl acetate 5
The mixture was dissolved in 0 ml, and 0.5 g of 5% Pd / C was added thereto to carry out normal-pressure catalytic hydrogenation. The blue color of the reaction solution disappeared and (2)
Generated.
【0062】次に反応液にトリエチルアミン1.2g、
及び無水トリフルオロ酢酸4.0gを加え室温で2時間
撹拌した。触媒及び不溶物を濾別し、残渣を酢酸エチル
から再結晶して目的の例示化合物9を4.0g(収率8
5%)得た。Next, 1.2 g of triethylamine was added to the reaction solution.
And 4.0 g of trifluoroacetic anhydride were added, followed by stirring at room temperature for 2 hours. The catalyst and insolubles were separated by filtration, and the residue was recrystallized from ethyl acetate to give 4.0 g of the desired Exemplified Compound 9 (yield 8
5%).
【0063】構造はNMRスペクトル及びMassスペ
クトルにより確認した。The structure was confirmed by NMR spectrum and Mass spectrum.
【0064】合成例3(例示化合物58の合成) 反応経路Synthesis Example 3 (Synthesis of Exemplified Compound 58) Reaction Route
【0065】[0065]
【化21】 Embedded image
【0066】メタノール30mlに例示化合物8を3.
5g溶解し、p−トルエンスルホン酸・1水和物2.6
gを加え撹拌する。Exemplified Compound 8 was added to 30 ml of methanol.
5 g was dissolved, and p-toluenesulfonic acid monohydrate 2.6
g and stirred.
【0067】次にこの反応液を水300mlにあけ、濾
取して目的の例示化合物58を4.1g(収率87%)
得た。Next, the reaction mixture was poured into 300 ml of water, and filtered to obtain 4.1 g of the desired Exemplified Compound 58 (yield 87%).
Obtained.
【0068】構造はNMRスペクトル及びMassスペ
クトルにより確認した。The structure was confirmed by NMR spectrum and Mass spectrum.
【0069】これ以外の化合物についても上記合成例と
同様の方法で容易に合成することができた。Other compounds could be easily synthesized in the same manner as in the above synthesis examples.
【0070】本発明の一般式(1)〜(4)で表される
ロイコ化合物の添加量としては医用感光材料においては
銀1molあたり1×10-6モル以上5×10-1モル未
満含有することが本特許の効果の発現には好ましく、こ
れ以下では銀色調の改良効果が小さく、これ以上では画
像全体が暗く感じられ好ましくない。さらに好ましく
は、銀1molあたり5×10-5モル以上5×10-2モ
ル未満含有する場合、特に銀1molあたり5×10-4
モル以上1×10-2モル未満含有する場合が効果の発現
において好ましい。The amount of the leuco compound represented by the general formulas (1) to (4) of the present invention is not less than 1 × 10 -6 mol and less than 5 × 10 -1 mol per mol of silver in a medical light-sensitive material. This is preferable for achieving the effects of the present patent. Below this, the effect of improving the silver tone is small, and above this, the entire image is dark, which is not preferable. More preferably, when it is contained at least 5 × 10 −5 mol and less than 5 × 10 −2 mol per mol of silver, particularly 5 × 10 −4 mol per mol of silver.
More than 1 mol and less than 1 × 10 -2 mol is preferable in terms of achieving the effect.
【0071】本発明の一般式(3)、(4)で表される
ロイコ化合物とRSO3Hのモル比は一般式(3)、
(4)で表される化合物1モルに対してRS03H1〜
3モルであることが好ましい。The molar ratio of the leuco compound represented by the general formulas (3) and (4) to RSO 3 H of the present invention is represented by the general formula (3):
RS0 3 H1 to 1 mol of the compound represented by (4)
Preferably it is 3 moles.
【0072】本発明のロイコ化合物を添加する層として
は、特に限定されないが、発色効率の点から考えると、
乳剤層により近接する層であることが好ましく、乳剤
層、または、乳剤層に接し、かつ乳剤層より上にある層
に含有するのが更に好ましい。The layer to which the leuco compound of the present invention is added is not particularly limited.
It is preferably a layer closer to the emulsion layer, and more preferably contained in the emulsion layer or a layer in contact with the emulsion layer and above the emulsion layer.
【0073】続いて、本発明に於けるマイクロカプセル
について説明する。Next, the microcapsules according to the present invention will be described.
【0074】本発明に於けるマイクロカプセルとは、少
なくとも一種類の写真用素材を、固体状態、溶液状態、
或いは該素材が粒子として存在している懸濁液状態で高
分子物質の壁により内包したリザーブ型(reserv
oir type)マイクロカプセルであっても良く、
高分子物質のマトリックス内に該素材を固体或いは溶液
状態で均一に或いは意識的に局在化させて分散したモノ
リス型(monolithic type)マイクロカ
プセル、いわゆるマイクロスフェアであっても良い。The microcapsule according to the present invention means that at least one kind of photographic material is used in a solid state, a solution state,
Alternatively, in a suspension state in which the material exists as particles, a reserve type (reservo
(or type) microcapsules,
Monolithic type microcapsules in which the material is uniformly or consciously localized and dispersed in a solid or solution state in a matrix of a polymer substance, so-called microspheres may be used.
【0075】本発明に用いるマイクロカプセルのポリマ
ー(高分子物質)としては、現像処理する前に、写真有
用化合物が不安定化するのを防止する目的があることか
らpH6以上、好ましくはpH7以上で溶解するポリマ
ーが良く、このようなアルカリ可溶性のポリマーの壁材
は現像処理工程中に溶解してハロゲン化銀写真感光材料
から溶出しても良いし、溶出しなくても良い。The polymer (polymeric substance) of the microcapsules used in the present invention has a pH of 6 or more, preferably 7 or more, for the purpose of preventing the photographically useful compound from being destabilized before the development processing. The polymer which dissolves is good, and the wall material of such an alkali-soluble polymer may or may not dissolve during the development step and elute from the silver halide photographic light-sensitive material.
【0076】本発明に於いて、マイクロカプセルの壁材
物質として有利に用いられるポリマーとしては、側鎖に
カルボキシル基、スルホン酸基等を有するビニル重合
体、縮合系ポリマーなどがあり、例えばビニル重合体と
しては、メタアクリル酸、アクリル酸、ビニルスルホン
酸等の側鎖にカルボキシル基、スルホン酸基を有する単
量体と、メタアクリル酸メチル、メタアクリル酸エチル
等のアクリル酸エステル類、スチレン、メチルスチレン
等のスチレン類、ビニルメチルケトン等の単量体との共
重合体等が挙げられ、側鎖にカルボキシル基、スルホン
酸基を有する単量体と、その他の単量体との組成比は4
0:60〜70:30(重量比)が好ましい。又、縮合
系ポリマーとしては、リジンとテレフタロイルクロライ
ド、アジピン酸クロライド、セバチン酸クロライド等の
多価カルボン酸塩化物との縮合物が挙げられる。これら
の他に分子内にカルボキシル基を有するカルボキシ基含
有セルロース誘導体等が挙げられる。In the present invention, examples of the polymer that is advantageously used as the wall material of the microcapsules include vinyl polymers having a carboxyl group or a sulfonic acid group in the side chain, condensation polymers, and the like. As a combination, methacrylic acid, acrylic acid, a monomer having a carboxyl group and a sulfonic acid group in a side chain such as vinyl sulfonic acid, and methyl methacrylate, acrylates such as ethyl methacrylate, styrene, Copolymers with styrenes such as methylstyrene and monomers such as vinyl methyl ketone, and the like, and the composition ratio of a monomer having a carboxyl group or a sulfonic acid group in a side chain and other monomers Is 4
0:60 to 70:30 (weight ratio) is preferred. Examples of the condensation polymer include a condensation product of lysine and a polycarboxylic acid chloride such as terephthaloyl chloride, adipic acid chloride, and sebacic acid chloride. In addition to these, a carboxy group-containing cellulose derivative having a carboxyl group in the molecule is exemplified.
【0077】本発明に於いて、マイクロカプセルの壁材
物質として用いられるポリマーを更に具体的に示せば、
ビニルポリマーであるメタアクリル酸(MAA)−メタ
アクリル酸メチル(MMA)共重合体(MAA/MMA
=40/60〜70/30(重量%))、アクリル酸メ
チル(MA)−メタアクリル酸エチル(MAE)共重合
体(MA/MAE=40/60〜70/30(重量
%))等のアクリル酸又はメタアクリル酸とアクリル酸
エステル又はメタアクリル酸エステルとの共重合体、ビ
ニルスルホン酸−メタアクリル酸エステル共重合体等の
カルボキシル基若しくはスルホ基又はこれらの塩を有す
るビニル系重合体、分子内にカルボキシル基を有する例
えばリジンとテレフタロイルクロライド等の酸塩化物と
の縮合系ポリマー、その他に分子内にカルボキシル基を
有するセルロース誘導体等が有利に用いられるものとし
て挙げられる。In the present invention, the polymer used as the wall material of the microcapsule can be more specifically described as follows:
Methacrylic acid (MAA) -methyl methacrylate (MMA) copolymer (MAA / MMA) which is a vinyl polymer
= 40/60 to 70/30 (% by weight)), and methyl acrylate (MA) -ethyl methacrylate (MAE) copolymer (MA / MAE = 40/60 to 70/30 (% by weight)). A copolymer of acrylic acid or methacrylic acid and an acrylic ester or a methacrylic ester, a vinyl polymer having a carboxyl group or a sulfo group or a salt thereof, such as a vinyl sulfonic acid-methacrylic ester copolymer, Condensation-type polymers having a carboxyl group in the molecule, such as lysine, and acid chlorides such as terephthaloyl chloride, and cellulose derivatives having a carboxyl group in the molecule can be advantageously used.
【0078】本発明のマイクロカプセルの壁材の膜厚
は、壁材の溶解性や、目的に応じて自由に変える事が出
来る。例えば、芯物質として内包した写真用素材の保存
時の安定性と現像処理時間の遅延防止の観点から膜厚を
任意に選択出来る。又、芯材の現像処理時間中の反応を
コントロールする為に、壁材の膜厚を変える等目的に応
じて壁材の膜厚を変える事が出来る。又、これらの芯材
の写真処理液中の作用効果のコントロールは、壁材膜厚
だけでなく、溶解速度の異なる高分子物質を選択して併
用する事によってもコントロール出来る。The thickness of the wall material of the microcapsule of the present invention can be freely changed depending on the solubility of the wall material and the purpose. For example, the film thickness can be arbitrarily selected from the viewpoint of stability during storage of the photographic material included as the core substance and prevention of delay in the development processing time. Further, in order to control the reaction of the core material during the development processing time, the thickness of the wall material can be changed according to the purpose such as changing the thickness of the wall material. In addition, the control of the effects of these core materials in the photographic processing solution can be controlled not only by the wall material film thickness but also by selecting and using polymer materials having different dissolution rates.
【0079】本発明のマイクロカプセルの半径粒径は5
μm以下が好ましい。より好ましくは1μm以下、更に
好ましくは、0.5μm以下である。The radius particle size of the microcapsule of the present invention is 5
μm or less is preferred. More preferably, it is 1 μm or less, further preferably, 0.5 μm or less.
【0080】本発明に於けるマイクロカプセルの製造
は、ポリマー中に内包或いは分散させた写真用素材の形
態にもよるが、相分離法、液中乾燥法、融解分散冷却
法、スプレードライング法、パンコーティング法、気中
懸濁被覆法、等の壁材物質を芯物質界面に沈積する界面
沈積法でも良く、界面重合法、内部重合法、外部重合
法、液中硬化被覆法、等の界面での反応を利用して壁を
形成させる界面反応法でも良い。The production of the microcapsules according to the present invention depends on the form of the photographic material encapsulated or dispersed in the polymer, but may be carried out by a phase separation method, a submerged drying method, a melt dispersion cooling method, a spray drying method, or the like. An interfacial deposition method of depositing a wall material such as a pan coating method or an air suspension coating method at a core material interface may be used, and an interface such as an interfacial polymerization method, an internal polymerization method, an external polymerization method, and a submerged hard coating method. An interface reaction method in which a wall is formed by utilizing the reaction in step (1) may be used.
【0081】次に、本発明に用いられるハロゲン化銀粒
子について説明する。Next, the silver halide grains used in the present invention will be described.
【0082】本発明に用いられるハロゲン化銀粒子とし
ては、特に制限はないが、平板状ハロゲン化銀粒子でア
スペクト比は3以上のものが好ましい。さらに好ましく
は3以上15未満である。3以上8未満が特に好まし
い。The silver halide grains used in the present invention are not particularly limited, but tabular silver halide grains having an aspect ratio of 3 or more are preferred. More preferably, it is 3 or more and less than 15. Particularly preferred is 3 or more and less than 8.
【0083】本発明に用いられるハロゲン化銀粒子はハ
ロゲン化銀として臭化銀、塩化銀、沃臭化銀、塩臭化
銀、沃塩化銀、塩沃臭化銀等を用いることができる。沃
化銀の含有量は、ハロゲン化銀粒子全体での平均沃化銀
含有率として1.0モル%以下が好ましいが、更には
0.5モル%以下が更に好ましい。In the silver halide grains used in the present invention, silver bromide, silver chloride, silver iodobromide, silver chlorobromide, silver iodochloride, silver chloroiodobromide and the like can be used as silver halide. The content of silver iodide is preferably 1.0 mol% or less, more preferably 0.5 mol% or less, as the average silver iodide content in the whole silver halide grains.
【0084】本発明に用いられる平板状ハロゲン化銀粒
子は米国特許5,320,938号記載の方法で作成す
ることが出来る。即ち、(100)面を形成しやすい条
件下で沃度イオンの存在下、低pClで核形成させるこ
とが好ましい。核形成後は、オストワルド熟成及び/又
は成長を行い、所望の粒径、分布を有する平板状ハロゲ
ン化銀粒子を得ることが出来る。本発明に用いられる平
板状ハロゲン化銀粒子は、いわゆるハロゲン変換型(コ
ンバージョン型)の粒子であっても構わない。ハロゲン
変換量は銀量に対して0.2モル%〜0.5モル%が好
ましく、変換の時期は物理熟成中でも物理熟成終了後で
も良い。The tabular silver halide grains used in the present invention can be prepared by the method described in US Pat. No. 5,320,938. That is, it is preferable to form nuclei with low pCl in the presence of iodine ions under conditions that facilitate formation of the (100) plane. After nucleation, Ostwald ripening and / or growth is performed to obtain tabular silver halide grains having a desired grain size and distribution. The tabular silver halide grains used in the present invention may be so-called halogen conversion type (conversion type) grains. The halogen conversion amount is preferably from 0.2 mol% to 0.5 mol% with respect to the silver amount, and the conversion may be performed during physical ripening or after completion of physical ripening.
【0085】ハロゲン化銀粒子は、粒子を形成する過程
及び/又は成長させる過程で、カドミウム塩、亜鉛塩、
鉛塩、タリウム塩、イリジウム塩(錯塩を含む)、ロジ
ウム塩(錯塩を含む)、ルテニウム塩(錯塩を含む)、
オスミニウム塩(錯塩を含む)、及び鉄塩(錯塩を含
む)から選ばれる少なくとも1種を用いて金属イオンを
添加し粒子内部及び/または粒子表面にこれらの金属元
素を含有させることが好ましい。During the process of forming and / or growing the silver halide grains, a cadmium salt, a zinc salt,
Lead salts, thallium salts, iridium salts (including complex salts), rhodium salts (including complex salts), ruthenium salts (including complex salts),
It is preferable that a metal ion is added using at least one selected from an osmium salt (including a complex salt) and an iron salt (including a complex salt) to contain these metal elements inside and / or on the surface of the particles.
【0086】本発明において現像速度を促進するために
脱塩工程前にハロゲン化銀溶剤を添加することも好まし
い。例えば、チオシアン酸化合物(チオシアン酸カリウ
ム、チオシアン酸ナトリウム、チオシアン酸アンモニウ
ム等)を銀1モル当たり1×10-3モル以上、3×10
-2モル以下加えることが好ましい。In the present invention, it is preferable to add a silver halide solvent before the desalting step in order to accelerate the developing speed. For example, a thiocyanate compound (potassium thiocyanate, sodium thiocyanate, ammonium thiocyanate, etc.) is used in an amount of 1 × 10 −3 mol or more and 3 × 10 3 mol or more per mol of silver.
It is preferable to add -2 mol or less.
【0087】本発明において、ハロゲン化銀粒子の保護
コロイド用分散媒としてはゼラチンを用いることが好ま
しく、ゼラチンとしてはアルカリ処理ゼラチン、酸処理
ゼラチン、低分子量ゼラチン(分子量が2万〜10
万)、フタル化ゼラチン等の修飾ゼラチンが用いられ
る。また、これ以外の親水性コロイドも使用できる。具
体的にはリサーチ・ディスクロージャー誌(Resea
rch Disclosure以下RDと略す)第17
6巻No.17643(1978年12月)の項に記載
されているものが挙げられる。In the present invention, gelatin is preferably used as a dispersion medium for the protective colloid of silver halide grains. As the gelatin, alkali-treated gelatin, acid-treated gelatin, low-molecular-weight gelatin (having a molecular weight of 20,000 to 10
And modified gelatin such as phthalated gelatin. Other hydrophilic colloids can also be used. Specifically, Research Disclosure Magazine (Resea
rch Disclosure (hereinafter abbreviated as RD) No. 17
No. 6 No. 17643 (December 1978).
【0088】本発明において、ハロゲン化銀粒子の成長
時に不要な可溶性塩類を除去してもよいし、或いは含有
させたままでもよい。該塩類を除去する場合にはRD第
176巻No.17643のII項に記載の方法に基づ
いて行うことができる。In the present invention, unnecessary soluble salts may be removed during the growth of silver halide grains, or they may be kept contained. When removing the salts, see RD Vol. It can be performed based on the method described in 17643, section II.
【0089】本発明のハロゲン化銀粒子は化学増感を施
すことができる。化学熟成即ち化学増感の工程の条件、
例えばpH、pAg、温度、時間等については特に制限
がなく、当業界で一般に行われている条件で行うことが
できる。化学増感のためには銀イオンと反応しうる硫黄
を含む化合物や活性ゼラチンを用いる硫黄増感法、セレ
ン化合物を用いるセレン増感法、テルル化合物を用いる
テルル増感法、還元性物質を用いる還元増感法、金その
他、貴金属を用いる貴金属増感法等を単独または組み合
わせて用いることができるが、なかでも、セレン増感
法、テルル増感法、還元増感法等が好ましく用いられ、
特にセレン増感法が好ましく用いられる。The silver halide grains of the present invention can be subjected to chemical sensitization. The conditions of the process of chemical ripening or chemical sensitization,
For example, the pH, pAg, temperature, time and the like are not particularly limited, and the reaction can be performed under conditions generally performed in the art. For chemical sensitization, sulfur sensitization using a compound containing sulfur that can react with silver ions or active gelatin, selenium sensitization using a selenium compound, tellurium sensitization using a tellurium compound, using a reducing substance Reduction sensitization, gold and other, noble metal sensitization using a noble metal and the like can be used alone or in combination, among which selenium sensitization, tellurium sensitization, reduction sensitization, etc. are preferably used,
In particular, a selenium sensitization method is preferably used.
【0090】セレン増感剤に関しては、米国特許1,5
74,944号、同1,602,592号、同1,62
3,499号、特開昭60−150046号、特開平4
−25832号、同4−109240号、同4−147
250号等に記載されている。Regarding the selenium sensitizer, US Pat.
74,944, 1,602,592, 1,62
3,499, JP-A-60-150046, JP-A-4
-25832, 4-109240, 4-147
No. 250, etc.
【0091】有用なセレン増感剤としては、コロイドセ
レン金属、イソセレノシアネート類(例えば、アリルイ
ソセレノシアネート等)、セレノ尿素類(例えば、N,
N−ジメチルセレノ尿素、N,N,N′−トリエチルセ
レノ尿素等)、セレノケトン類(例えば、セレノアセト
ン、セレノアセトフェノン等)、セレノアミド類(例え
ば、セレノアセトアミド、N,N−ジメチルセレノベン
ズアミド等)、セレノカルボン酸類及びセレノエステル
類(例えば、2−セレノプロピオン酸、メチル−3−セ
レノブチレート等)、セレノフォスフェート類(例え
ば、トリ−p−トリセレノフォスフェート等)、セレナ
イド類(ジエチルセレナイド、ジエチルジセレナイド、
トリフェニルフォスフィンセレナイド等)が挙げられ
る。特に、好ましいセレン増感剤は、セレノ尿素類、セ
レノアミド類、及びセレンケトン類である。Useful selenium sensitizers include colloidal selenium metal, isoselenocyanates (eg, allyl isoselenocyanate, etc.), and selenoureas (eg, N,
N-dimethylselenourea, N, N, N'-triethylselenourea, etc., selenoketones (eg, selenoacetone, selenoacetophenone, etc.), selenoamides (eg, selenoacetamide, N, N-dimethylselenobenzamide, etc.), Selenocarboxylic acids and selenoesters (eg, 2-selenopropionic acid, methyl-3-selenobutyrate, etc.), selenophosphates (eg, tri-p-triselenophosphate, etc.), selenides (diethylselenide) , Diethyl diselenide,
Triphenylphosphine selenide). Particularly preferred selenium sensitizers are selenoureas, selenamides, and selenium ketones.
【0092】セレン増感剤の使用量は使用するセレン化
合物、ハロゲン化銀粒子、化学熟成条件等により変わる
が、一般にハロゲン化銀1モル当たり10-8モル〜10
-4モル程度を用いる。また、添加方法は、使用するセレ
ン化合物の性質に応じて、水またはメタノール、エタノ
ール、酢酸エチルなどの有機溶媒の単独または混合溶媒
に溶解して添加する方法でも、或いは、ゼラチン溶液と
予め混合して添加する方法でも、特開平4−14073
9号に開示されている方法、即ち、有機溶媒可溶性の重
合体との混合溶液の乳化分散物の形態で添加する方法で
も良い。[0092] The amount of the selenium sensitizer selenium compound used, the silver halide grains will vary by the chemical ripening condition and the like, generally per mol of silver halide 10 -8 mol to 10
Use about -4 moles. Depending on the properties of the selenium compound to be used, the addition method may be a method of dissolving in water or an organic solvent such as methanol, ethanol or ethyl acetate alone or in a mixed solvent, or a method of preliminarily mixing with a gelatin solution. Also, the method of adding
No. 9, that is, a method of adding in the form of an emulsified dispersion of a mixed solution with an organic solvent-soluble polymer.
【0093】本発明の実施に際して用いられるハロゲン
化銀乳剤は、シアニン色素類その他によって分光増感さ
れてもよい。増感色素は単独に用いてもよいが、それら
の組み合わせを用いてもよく、増感色素の組み合わせは
特に強色増感の目的でしばしば用いられる。The silver halide emulsion used in the practice of the present invention may be spectrally sensitized with a cyanine dye or the like. The sensitizing dye may be used alone, or a combination thereof may be used. The combination of sensitizing dyes is often used particularly for supersensitization.
【0094】本発明の感光材料が医療用両面乳剤X線感
材として利用される場合は、画像鮮鋭性を向上させる目
的で、横断光遮断層を設けることが好ましい。該横断光
遮断層には横断光を吸収させる目的で染料の固体微粒子
分散体が含有される。このような染料としては、例えば
pH9以上のアルカリには可溶で、pH7以下では難溶
な構造を有する染料であれば特に制限はないが、現像処
理時の脱色性がよい点で特開平6−308670号記載
の一般式(I)の化合物が好ましく用いられる。When the light-sensitive material of the present invention is used as a double-sided emulsion X-ray light-sensitive material for medical use, it is preferable to provide a transverse light blocking layer for the purpose of improving image sharpness. The transverse light blocking layer contains a solid fine particle dispersion of a dye for the purpose of absorbing transverse light. Such a dye is not particularly limited as long as it has a structure that is soluble in an alkali having a pH of 9 or more and has a structure that is hardly soluble at a pH of 7 or less. The compound of the general formula (I) described in JP-A-308670 is preferably used.
【0095】本発明のハロゲン化銀乳剤による感光材料
は、乳剤の物理熟成又は化学熟成前後の工程で、各種の
写真用添加剤を用いることができる。In the light-sensitive material using the silver halide emulsion of the present invention, various photographic additives can be used before and after physical ripening or chemical ripening of the emulsion.
【0096】このような工程で使用できる化合物として
は例えば、前記のリサーチ・ディスクロージャー(R
D)17643号、(RD)18716号(1979年
11月)及び(RD)308119号(1989年12
月)に記載されている各種の化合物が挙げられる。これ
ら3つの(RD)に記載されている化合物の種類と記載
箇所を下記に掲載した。Compounds that can be used in such a step include, for example, the aforementioned Research Disclosure (R
D) 17643, (RD) 18716 (November 1979) and (RD) 308119 (December 1989)
Month). The types and locations of the compounds described in these three (RD) are described below.
【0097】[0097]
【表1】 [Table 1]
【0098】本発明の感光材料に用いられる支持体とし
ては、上記のRDに記載されているものが挙げられる
が、適当な支持体としてはプラスチックフィルムなど
で、支持体表面は塗布層の接着性をよくするために下引
き層を設けたり、コロナ放電や紫外線照射などが施され
てもよい。そして、このように処理された支持体上の両
面に本発明に係る乳剤を塗布することができる。本発明
の感光材料には、他に必要に応じて、アンチハレーショ
ン層、中間層、フィルター層などを設けることができ
る。Examples of the support used in the light-sensitive material of the present invention include those described in the above-mentioned RD. A suitable support is a plastic film or the like. In order to improve the performance, an undercoat layer may be provided, or corona discharge or ultraviolet irradiation may be applied. Then, the emulsion according to the present invention can be coated on both sides of the support thus treated. The light-sensitive material of the present invention may further include an antihalation layer, an intermediate layer, a filter layer, and the like, if necessary.
【0099】本発明の感光材料において、ハロゲン化銀
乳剤層その他の親水性コロイド層は種々の塗布法により
支持体上または他の層上に塗布できる。塗布には、ディ
ップ塗布法、ローラー塗布法、カーテン塗布法、押しだ
し塗布法、スライド・ホッパー法などを用いることがで
きる。詳しくは、リサーチ・ディスクロージャー,第1
76巻,27−28頁の「Coating proce
dures」の項に記載されている方法を用いうる。In the light-sensitive material of the present invention, a silver halide emulsion layer and other hydrophilic colloid layers can be coated on a support or other layers by various coating methods. For the coating, a dip coating method, a roller coating method, a curtain coating method, an extrusion coating method, a slide hopper method, or the like can be used. For details, see Research Disclosure, No. 1.
Vol. 76, p. 27-28, "Coating process"
dures "section.
【0100】本発明の感光材料の処理は例えば、前記の
RD−17643のXX〜XXI,29〜30頁或いは同3
08119のXX〜XXI,1011〜1012頁に記載さ
れているような処理液による処理がなされてよい。The processing of the light-sensitive material of the present invention is carried out, for example, in the manner described in RD-17643, pages XX to XXI, pp. 29 to 30 or 3 above.
Treatment with a treatment solution as described in 08119, XX to XXI, pp. 1011 to 1012 may be performed.
【0101】白黒写真処理での現像剤としては、ジヒド
ロキシベンゼン類(例えばハイドロキノン)、3−ピラ
ゾリドン類(例えば1−フェニル−3−ピラゾリド
ン)、アミノフェノール類(例えばN−メチル−アミノ
フェノール)などを単独もしくは組み合わせて用いるこ
とができる。なお、現像液には公知の例えば保恒剤、ア
ルカリ剤、pH緩衝剤、カブリ防止剤、硬膜剤、現像促
進剤、界面活性剤、消泡剤、色調剤、硬水軟化剤、溶解
助剤、粘性付与剤などを必要に応じて用いてもよい。Examples of the developer for black-and-white photographic processing include dihydroxybenzenes (eg, hydroquinone), 3-pyrazolidones (eg, 1-phenyl-3-pyrazolidone), and aminophenols (eg, N-methyl-aminophenol). They can be used alone or in combination. In the developer, a known agent such as a preservative, an alkali agent, a pH buffer, an antifoggant, a hardener, a development accelerator, a surfactant, an antifoaming agent, a color tone agent, a water softener, and a dissolution aid can be used. A viscosity imparting agent may be used as necessary.
【0102】定着液にはチオ硫酸塩、チオシアン酸塩な
どの定着剤が用いられ、さらに硬膜剤として水溶性のア
ルミニウム塩例えば硫酸アルミニウム或いはカリ明ばん
などを含んでいてもよい。その他保恒剤、pH調整剤、
硬水軟化剤などを含有していてもよい。The fixing solution contains a fixing agent such as thiosulfate and thiocyanate, and may further contain a water-soluble aluminum salt such as aluminum sulfate or potassium alum as a hardening agent. Other preservatives, pH adjusters,
It may contain a water softener or the like.
【0103】本発明においては、自動現像機で全処理時
間(Dry to Dry)が15〜60秒の超迅速処
理することも可能である。ここでいう“現像工程時間”
又は“現像時間”とは、処理する感光材料の先端が自動
現像機(以下、自現機と呼ぶ)の現像タンク液に浸漬し
てから次の定着液に浸漬するまでの時間、“定着時間”
とは定着タンク液に浸漬してから次の水洗タンク液(安
定液)に浸漬するまでの時間、“水洗時間”とは、水洗
タンク液に浸漬している時間をいう。また“乾燥時間”
とは、通常自現機には、好ましくは35℃〜100℃、
より好ましくは40℃〜80℃の熱風が吹きつけられる
乾燥ゾーンが設置されており、その乾燥ゾーンに入って
いる時間をいう。In the present invention, it is possible to perform ultra-rapid processing with a total processing time (Dry to Dry) of 15 to 60 seconds by an automatic developing machine. "Developing process time" here
Alternatively, the term “development time” refers to the time from when the leading edge of the photosensitive material to be processed is immersed in a developing tank solution of an automatic developing machine (hereinafter referred to as an automatic developing machine) to when it is immersed in the next fixing solution. "
"Washing time" refers to the time from immersion in the fixing tank solution to immersion in the next washing tank solution (stabilizing solution). Also "drying time"
And usually, in the automatic machine, preferably 35 ℃ ~ 100 ℃,
More preferably, a drying zone in which hot air of 40 ° C. to 80 ° C. is blown is provided, and it refers to a time in the drying zone.
【0104】本発明においては、現像、定着等の処理で
は、処理時間が15秒以下、処理温度は好ましくは25
℃〜50℃であるが、より好ましくは30℃〜40℃で
2秒〜10秒である。In the present invention, in processing such as development and fixing, the processing time is 15 seconds or less, and the processing temperature is preferably 25 seconds.
C. to 50C, more preferably 30C to 40C for 2 seconds to 10 seconds.
【0105】本発明においては、現像、定着及び水洗
(又は安定化)された感光材料は水洗水をしぼり切るス
クイズローラーを経て乾燥される。水洗工程は、5〜5
0℃で2〜10秒が好ましい。In the present invention, the developed, fixed and washed (or stabilized) photosensitive material is dried through a squeeze roller for squeezing the washing water. Washing process is 5-5
It is preferably at 0 ° C. for 2 to 10 seconds.
【0106】本発明では現像、定着、水洗された感光材
料はスクイズローラーを経て乾燥される。乾燥方式は、
熱風対流乾燥、遠赤外線ヒーターによる放射乾燥、ヒー
トローラーによる伝熱乾燥のいずれか又は併用すること
ができる。乾燥温度と時間は40〜100℃で4〜15
秒で行われることが好ましい。In the present invention, the photosensitive material which has been developed, fixed and washed with water is dried via a squeeze roller. The drying method is
Either hot air convection drying, radiation drying using a far-infrared heater, or heat transfer drying using a heat roller, or a combination thereof can be used. Drying temperature and time are 4 ~ 15 at 40 ~ 100 ° C
It is preferably done in seconds.
【0107】本発明においては、現像液や定着液の補充
量が感光材料1m2当たり35〜130mlで処理する
ことが好ましい。補充方法としては、特開昭55−12
6243号に記載の幅、送り速度による補充、特開昭6
0−104946号記載の面積補充、特開平1−149
156号記載の連続処理枚数によりコントロールされた
面積補充でもよい。In the present invention, the processing is preferably carried out at a replenishment amount of the developing solution and the fixing solution of 35 to 130 ml per m 2 of the photographic material. As a replenishment method, JP-A-55-12
No. 6243, replenishment by width and feed speed.
No. 0-104946, area replenishment, JP-A-1-149
No. 156, the area replenishment controlled by the number of continuously processed sheets may be used.
【0108】[0108]
【実施例】以下、実施例を挙げて本発明を詳細に説明す
るが、本発明の態様はこれに限定されない。EXAMPLES The present invention will be described below in detail with reference to examples, but embodiments of the present invention are not limited thereto.
【0109】(本発明のロイコ化合物の分散物の調製) 《リザーブ型マイクロカプセル液A−1〜A−3の調
製》下記I液およびII液を、高速撹拌型分散機を用いて
乳化分散し、系内を減圧にすることにより塩化メチレン
の除去を行い、本発明のロイコ化合物の例示化合物N
o.76内包の平均粒径0.2μmのマイクロカプセル
液を得た。更に、該マイクロカプセル液を純水にて70
0gに仕上げることにより、該マイクロカプセル液中
の、本発明のロイコ化合物の例示化合物No.76の濃
度を0.5wt%に調整して、リザーブ型マイクロカプ
セル液A−1を得た。(Preparation of Dispersion of Leuco Compound of the Present Invention) << Preparation of Reserve Type Microcapsule Solutions A-1 to A-3 >> The following solutions I and II were emulsified and dispersed using a high-speed stirring type disperser. The pressure in the system was reduced to remove methylene chloride, and the exemplary compound N of the leuco compound of the present invention was removed.
o. A microcapsule solution containing 76 inclusions and having an average particle size of 0.2 μm was obtained. Further, the microcapsule liquid was purified with pure water for 70 minutes.
0 g of the compound No. 1 of the leuco compound of the present invention in the microcapsule liquid. The concentration of No. 76 was adjusted to 0.5% by weight to obtain a reserve type microcapsule solution A-1.
【0110】更に、本発明のロイコ化合物の例示化合物
No.76を、No.79,No.57に代えた他はA
−1の調製と同様にしてリザーブ型マイクロカプセル液
A−2,A−3をそれぞれ調製した。Further, the exemplified compound No. of the leuco compound of the present invention was obtained. No. 76, 79, no. A except for 57
In the same manner as in the preparation of -1, reserve type microcapsule solutions A-2 and A-3 were respectively prepared.
【0111】 I液 塩化メチレン 200g トリクレジルフォスフェート 10.5g メタアクリル酸とメタアクリル酸メチルの1:2共重合体 (pH=7以上で溶解) 3.15g 本発明のロイコ化合物の例示化合物No.76 3.50g II液 写真用ゼラチン 52.5g 界面活性剤(トリイソプロピル−β−ナフタレンスルホン酸ソーダ) 0.590g 純水 297g 《リザーブ型マイクロカプセル液B−1〜B−3の調
製》メタアクリル酸とメタアクリル酸メチルの1:2共
重合体を6.20gとした以外は上記リザーブ型マイク
ロカプセル液A−1の調製と全て同様にして、平均粒径
0.2μmの本発明のロイコ化合物の例示化合物No.
76の濃度が0.5wt%である該化合物No.76内
包のマイクロカプセル液であるリザーブ型マイクロカプ
セル液B−1を得た。Solution I Methylene chloride 200 g Tricresyl phosphate 10.5 g 1: 2 copolymer of methacrylic acid and methyl methacrylate (dissolved at pH = 7 or more) 3.15 g Exemplary compound of leuco compound of the present invention No. 76 3.50 g II solution Gelatin for photography 52.5 g Surfactant (sodium triisopropyl-β-naphthalenesulfonate) 0.590 g Pure water 297 g << Preparation of reserve type microcapsule solutions B-1 to B-3 >> Methacryl The leuco compound of the present invention having an average particle size of 0.2 μm was prepared in the same manner as in the preparation of the reserve type microcapsule solution A-1 except that the amount of the 1: 2 copolymer of acid and methyl methacrylate was changed to 6.20 g. Exemplified Compound No.
No. 76 having a concentration of 0.5 wt%. A reserve-type microcapsule solution B-1 which is a microcapsule solution containing 76 was obtained.
【0112】更に、本発明のロイコ化合物の例示化合物
No.76を、No.79,No.57に代えた他はB
−1の調製と同様にしてリザーブ型マイクロカプセル液
B−2,B−3をそれぞれ調製した。Further, the exemplified leuco compounds of the present invention, Compound No. No. 76, 79, no. B instead of 57
In the same manner as in the preparation of -1, reserve type microcapsule solutions B-2 and B-3 were prepared.
【0113】《モノリス型マイクロカプセル液C−1〜
C−3の調製》メタアクリル酸とメタアクリル酸メチル
の1:2共重合体1.80gと本発明のロイコ化合物の
例示化合物No.76を1.80g含有するメタノール
溶液60.0gを、撹拌翼周速7m/secの撹拌下に
ある0.1mmolクエン酸ナトリウム水溶液2,40
0g中に1g/minの速度で滴下し、平均径0.3μ
mのモノリス型マイクロカプセル液Cを調製した。<< Monolith type microcapsule liquid C-1 ~
Preparation of C-3 >> 1.80 g of a 1: 2 copolymer of methacrylic acid and methyl methacrylate and Exemplified Compound No. 1 of the leuco compound of the present invention. 60.0 g of a methanol solution containing 1.80 g of 76 are mixed with an aqueous 0.1 mmol sodium citrate solution 2,40 under stirring at a stirring blade peripheral speed of 7 m / sec.
0 g was dropped at a rate of 1 g / min, and the average diameter was 0.3 μm.
m of the monolithic microcapsule liquid C was prepared.
【0114】引き続き、該マイクロカプセル液を限外濾
過により360gまで濃縮する事により、本発明のロイ
コ化合物の例示化合物No.76の濃度が0.5wt%
であるモノリス型マイクロカプセル液C−1を調製し
た。Subsequently, the microcapsule solution was concentrated to 360 g by ultrafiltration to give the leuco compound of the present invention. The concentration of 76 is 0.5wt%
Was prepared as a monolithic microcapsule liquid C-1.
【0115】更に、本発明のロイコ化合物の例示化合物
No.76を、No.79,No.57に代えた他はC
−1の調製と同様にしてモノリス型マイクロカプセル液
C−2,C−3をそれぞれ調製した。Further, the exemplified leuco compounds of the present invention, Compound No. No. 76, 79, no. C instead of 57
Monolithic microcapsule liquids C-2 and C-3 were prepared in the same manner as in the preparation of -1.
【0116】《モノリス型マイクロカプセル液D−1〜
D−3(比較例)の調製》モノリス型マイクロカプセル
液C−1において、メタアクリル酸とメタアクリル酸メ
チル1:2共重合体をメタアクリル酸メチルとメタアク
リル酸ブチルとメタアクリル酸ジメチルアミノメチルの
2:1:1共重合体(pH=5以下で溶解)とした以外
は、モノリス型マイクロカプセル液C−1と全て同様に
して、平均粒径0.3μmの本発明のロイコ化合物の例
示化合物No.76の濃度が0.5wt%であるモノリ
ス型マイクロカプセル液D−1を調製した。<< Monolith Type Microcapsule Liquid D-1 ~
Preparation of D-3 (Comparative Example) >> In the monolith type microcapsule liquid C-1, a methacrylic acid and methyl methacrylate 1: 2 copolymer were converted to methyl methacrylate, butyl methacrylate and dimethylamino methacrylate. Except for using a 2: 1: 1 copolymer of methyl (dissolved at pH = 5 or less), the same procedure as in the monolithic microcapsule liquid C-1 was carried out to obtain the leuco compound of the present invention having an average particle diameter of 0.3 μm. Exemplified Compound No. A monolithic microcapsule solution D-1 having a concentration of 76 of 0.5 wt% was prepared.
【0117】更に、本発明のロイコ化合物の例示化合物
No.76を、No.79,No.57に代えた他はD
−1の調製と同様にしてモノリス型マイクロカプセル液
D−2,D−3をそれぞれ調製した。Further, the exemplified compound No. No. 76, 79, no. D instead of 57
Monolithic microcapsule solutions D-2 and D-3 were prepared in the same manner as in the preparation of -1.
【0118】《本発明のロイコ化合物のメタノール溶液
E−1〜E−3(比較例)の調製》本発明のロイコ化合
物の例示化合物No.76の1wt%メタノール溶液を
作製して、本発明のロイコ化合物のメタノール溶液E−
1とした。<< Preparation of Methanol Solutions E-1 to E-3 of the Leuco Compounds of the Present Invention (Comparative Examples) >> 76 was prepared, and a methanol solution E- of the leuco compound of the present invention was prepared.
It was set to 1.
【0119】更に、本発明のロイコ化合物の例示化合物
No.76を、No.79,No.57に代えた他はE
−1の調製と同様にして本発明のロイコ化合物のメタノ
ール溶液E−2,E−3をそれぞれ調製した。Furthermore, the exemplified compound No. No. 76, 79, no. E instead of 57
-1, methanol solutions E-2 and E-3 of the leuco compound of the present invention were respectively prepared.
【0120】続いて、実施例に使用する種乳剤及び乳剤
の調製方法を示す。Next, the seed emulsion used in the examples and the method of preparing the emulsion will be described.
【0121】 (種乳剤−1の調製) A1 オセインゼラチン 24.2g 水 9657ml ポリプロピレンオキシ−ポリエチレンオキシ−ジサクシ ネートナトリウム塩(10%エタノール水溶液) 6.78ml 臭化カリウム 10.8g 10%硝酸 114ml B1 2.5N 硝酸銀水溶液 2825ml C1 臭化カリウム 824g 沃化カリウム 23.5g 水で 2825mlに仕上げる D1 1.75N 臭化カリウム水溶液 下記銀電位制御量 35℃で特公昭58−58288号、同58−5828
9号記載の混合撹拌機を用い溶液A1に溶液B1及び溶
液C1の各々464.3mlを同時混合法により1.5
分を要して添加し、核形成を行った。(Preparation of Seed Emulsion-1) A1 Ossein gelatin 24.2 g Water 9657 ml Polypropylene oxy-polyethylene oxy-disuccinate sodium salt (10% aqueous ethanol) 6.78 ml Potassium bromide 10.8 g 10% nitric acid 114 ml B1 2.5N silver nitrate aqueous solution 2825ml C1 potassium bromide 824g potassium iodide 23.5g Make up to 2825ml with water D1 1.75N potassium bromide aqueous solution The following silver potential control amount 35 ° C, JP-B-58-58288, 58-5828
Using a mixing stirrer described in No. 9, 464.3 ml of each of the solution B1 and the solution C1 was added to the solution A1 by a simultaneous mixing method.
Nucleation was performed by adding over a minute.
【0122】溶液B1及び溶液C1の添加を停止した
後、60分の時間を要して溶液A1の温度を60℃に上
昇させ、3%KOHでpHを5.0に合わせた後、再び
溶液B1と溶液C1を同時混合法により各々55.4m
l/minの流量で42分間添加した。この35℃から
60℃への昇温及び溶液B1、C1による再同時混合の
間の銀電位(飽和銀−塩化銀電極を比較電極として銀イ
オン選択電極で測定)を溶液D1を用いてそれぞれ+8
mV及び+16mVになるよう制御した。After stopping the addition of the solution B1 and the solution C1, it takes 60 minutes to raise the temperature of the solution A1 to 60 ° C., adjust the pH to 5.0 with 3% KOH, and then again Each of B1 and solution C1 was 55.4 m by a simultaneous mixing method.
It was added at a flow rate of 1 / min for 42 minutes. The silver potential (measured with a silver ion selective electrode using a saturated silver-silver chloride electrode as a reference electrode) during the temperature rise from 35 ° C. to 60 ° C. and the re-simultaneous mixing with the solutions B1 and C1 was +8 using the solution D1.
mV and +16 mV.
【0123】添加終了後、3%KOHによってpHを6
に合わせ直ちに脱塩、水洗を行った。この種乳剤はハロ
ゲン化銀粒子の全投影面積の90%以上が最大隣接辺比
が1.0〜2.0の六角平板粒子よりなり、六角平板粒
子の平均厚さは0.06μm、平均粒径(円直径換算)
は0.59μmであることを電子顕微鏡にて確認した。
また厚さの変動係数は40%、双晶面間距離の変動係数
は42%であった。After the addition was completed, the pH was adjusted to 6 with 3% KOH.
Immediately, desalting and washing were performed. In this seed emulsion, 90% or more of the total projected area of silver halide grains is composed of hexagonal tabular grains having a maximum adjacent side ratio of 1.0 to 2.0, and the average thickness of the hexagonal tabular grains is 0.06 μm. Diameter (converted to circle diameter)
Was confirmed to be 0.59 μm by an electron microscope.
The variation coefficient of the thickness was 40%, and the variation coefficient of the distance between twin planes was 42%.
【0124】(Em−1の調製)上記の種乳剤−1と以
下に示す4種の溶液を用い、コア/シェル型構造を有す
る平板状乳剤を調製した。(Preparation of Em-1) A tabular emulsion having a core / shell structure was prepared using the above seed emulsion-1 and the following four kinds of solutions.
【0125】 A2 オセインゼラチン 11.7g ポリプロピレンオキシ−ポリエチレンオキシ −ジサクシネートナトリウム塩(10%エタノール水溶液) 1.4ml 種乳剤−1 0.10モル相当量 水で 550mlに仕上げる B2 オセインゼラチン 5.9g 臭化カリウム 6.2g 沃化カリウム 0.8g 水で 145mlに仕上げる C2 硝酸銀 10.1g 水で 145mlに仕上げる D2 オセインゼラチン 6.1g 臭化カリウム 94g 水で 304mlに仕上げる E2 硝酸銀 137g 水で 304mlに仕上げる 67℃で激しく撹拌したA2液に、ダブルジェット法に
てB2液とC2液を58分で添加した。次に同じ液中に
D2液とE2液をダブルジェット法にて48分添加し
た。この間、pHは5.8、pAgは8.7に保った。A2 Ossein gelatin 11.7 g Polypropylene oxy-polyethylene oxy-disuccinate sodium salt (10% aqueous solution of ethanol) 1.4 ml Seed emulsion-1 0.10 mol equivalent Equivalent to 550 ml with water B2 Oscein gelatin 5 9.9 g Potassium bromide 6.2 g Potassium iodide 0.8 g Finish to 145 ml with water C2 Silver nitrate 10.1 g Finish to 145 ml with water D2 Ossein gelatin 6.1 g Potassium bromide 94 g Finish to 304 ml with water E2 137 g with silver nitrate Finish up to 304 ml. Solution B2 and solution C2 were added by double jet method to solution A2 which was vigorously stirred at 67 ° C. in 58 minutes. Next, solution D2 and solution E2 were added to the same solution by a double jet method for 48 minutes. During this time, the pH was kept at 5.8 and the pAg was kept at 8.7.
【0126】添加終了後、種乳剤−1と同様に脱塩、沈
澱を行い40℃にてpAg8.5、pH5.85の平均
沃化銀含有率が約0.5モル%の乳剤を得た。After completion of the addition, desalting and precipitation were carried out in the same manner as in Seed Emulsion 1 to obtain an emulsion having a pAg of 8.5 and a pH of 5.85 at 40 ° C. and an average silver iodide content of about 0.5 mol%. .
【0127】得られた乳剤を電子顕微鏡にて観察したと
ころ、投影面積の81%が平均粒径0.96μm、粒径
分布の広さが19%で、平均アスペクト比4.5の平板
状ハロゲン化銀粒子であった。また双晶面間距離(a)
の平均は0.019μmであり、(a)の変動係数は2
8%であった。The obtained emulsion was observed with an electron microscope. As a result, 81% of the projected area had a mean grain size of 0.96 μm, the grain size distribution was 19%, and the average aspect ratio was 4.5. It was silver halide particles. The twin plane distance (a)
Is 0.019 μm, and the variation coefficient of (a) is 2
8%.
【0128】得られた乳剤Em−1を60℃に昇温し、
分光増感色素の所定量を、固体微粒子状の分散物として
添加した後に、アデニン、チオシアン酸アンモニウム、
塩化金酸及びチオ硫酸ナトリウムの混合水溶液及びトリ
フェニルフォスフィンセレナイドを酢酸エチルとメタノ
ールの混合溶媒に溶かして得た溶液を加え、更に60分
後に沃化銀微粒子乳剤を加え、総計2時間の熟成を施し
た。熟成終了時に安定剤として4−ヒドロキシ−6−メ
チル−1,3,3a,7−テトラザインデン(TAI)
の所定量を添加した。The temperature of the obtained emulsion Em-1 was raised to 60 ° C.
After adding a predetermined amount of the spectral sensitizing dye as a solid particulate dispersion, adenine, ammonium thiocyanate,
A mixed aqueous solution of chloroauric acid and sodium thiosulfate and a solution obtained by dissolving triphenylphosphine selenide in a mixed solvent of ethyl acetate and methanol were added. After 60 minutes, a silver iodide fine grain emulsion was added, and a total of 2 hours was added. Aged. At the end of ripening, 4-hydroxy-6-methyl-1,3,3a, 7-tetrazaindene (TAI) is used as a stabilizer.
Was added in a predetermined amount.
【0129】上記の添加剤とその添加量(AgX1モル
当たり)を下記に示す。The above additives and their amounts (per mole of AgX) are shown below.
【0130】 分光増感色素(A) 120mg 分光増感色素(B) 2.0mg アデニン 15mg チオシアン酸カリウム 95mg 塩化金酸 2.5mg チオ硫酸ナトリウム 2.0mg トリフェニルフォスフィンセレナイド 0.4mg 沃化銀微粒子 280mg 4−ヒドロキシ−6−メチル−1,3,3a,7−テト ラザインデン(TAI) 50mg 分光増感色素の固体微粒子状分散物は、特願平4−99
437号に記載の方法に準じて調製した。即ち分光増感
色素の所定量を予め27℃に調温した水に加え、高速撹
拌機(ディゾルバー)で,500rpmにて30〜12
0分間にわたって撹拌することによって得た。Spectral sensitizing dye (A) 120 mg Spectral sensitizing dye (B) 2.0 mg Adenine 15 mg Potassium thiocyanate 95 mg Chloroauric acid 2.5 mg Sodium thiosulfate 2.0 mg Triphenylphosphine selenide 0.4 mg Iodide Silver fine particles 280 mg 4-Hydroxy-6-methyl-1,3,3a, 7-tetrazaindene (TAI) 50 mg A solid fine particle dispersion of a spectral sensitizing dye is disclosed in Japanese Patent Application No. 4-99.
Prepared according to the method described in No. 437. That is, a predetermined amount of the spectral sensitizing dye is added to water whose temperature has been previously adjusted to 27 ° C., and a high-speed stirrer (dissolver) is used for 30 to 12 at 500 rpm.
Obtained by stirring for 0 minutes.
【0131】 増感色素(A):5,5′−ジクロロ−9−エチル−
3,3′−ジ−(スルホプロピル)オキサカルボシアニ
ン−ナトリウム塩 無水物 増感色素(B):5,5′−ジ−(ブトキシカルボニ
ル)−1,1′−ジエチル−3,3’−ジ−(4−スル
ホブチル)ベンゾイミダゾロカルボシアニン−ナトリウ
ム塩 無水物 以下の塗布液を、下引き処理済のブルーに着色した厚さ
175μのポリエチレンテレフタレート支持体の両面に
下から横断光遮光層、乳剤層、乳剤保護層の順に同時重
層塗布、乾燥した。Sensitizing dye (A): 5,5′-dichloro-9-ethyl-
3,3'-di- (sulfopropyl) oxacarbocyanine-sodium salt anhydride Sensitizing dye (B): 5,5'-di- (butoxycarbonyl) -1,1'-diethyl-3,3'- Di- (4-sulfobutyl) benzimidazolocarbocyanine-sodium salt Anhydrous The following coating solution was applied to both sides of a 175 μm thick polyethylene terephthalate support, which had been subjected to a subbing treatment, and a transverse light-shielding layer from below, An emulsion layer and an emulsion protective layer were simultaneously coated in order and dried.
【0132】 (試料の作成) 第1層(横断光遮光層) 固体微粒子分散体染料(AH) 50mg/m2 ゼラチン 0.2mg/m2 ドデシルベンゼンスルホン酸ナトリウム 5mg/m2 化合物(I) 5mg/m2 2,4−ジクロロ−6−ヒドロキシ−1,3,5−トリア ジンンナトリウム塩 5mg/m2 ポリスチレンスルホン酸カリウム 50mg/m2 第2層(乳剤層) 上記で得た乳剤(Em−1)に下記の各種添加剤を加えた。(Preparation of Sample) First Layer (Transverse Light Shielding Layer) Solid Fine Particle Dispersion Dye (AH) 50 mg / m 2 Gelatin 0.2 mg / m 2 Sodium Dodecylbenzenesulfonate 5 mg / m 2 Compound (I) 5 mg / M 2 2,4-Dichloro-6-hydroxy-1,3,5-triazine sodium salt 5 mg / m 2 Potassium polystyrene sulfonate 50 mg / m 2 Second layer (emulsion layer) Emulsion obtained above (Em The following various additives were added to -1).
【0133】 テトラクロロパラジウム(2)酸カリウム 100mg/m2 化合物(G) 0.5mg/m2 2,6−ビス(ヒドロキシアミノ)−4−ジエチルアミノ− 1,3,5−トリアジン 5mg/m2 t−ブチル−カテコール 130mg/m2 ポリビニルピロリドン(分子量10,000) 35mg/m2 ポリスチレンスルホン酸ナトリウム 80mg/m2 トリメチロールプロパン 50mg/m2 ジエチレングリコール 50mg/m2 ニトロフェニル−トリフェニル−ホスホニウムクロリド 20mg/m2 1,3−ジヒドロキシベンゼン−4−スルホン酸アンモニウム 100mg/m2 2−メルカプトベンツイミダゾール−5−スルホン酸ナトリウム 5mg/m2 化合物(H) 0.5mg/m2 n−C4H9OCH2CH(OH)CH2N(CH2COOH)2 35mg/m2 化合物(M) 5mg/m2 化合物(N) 5mg/m2 コロイダルシリカ(平均粒径0.014μm) 500mg/m2 ラテックス(L) 500mg/m2 デキストラン(平均分子量40,000) 100mg/m2 本発明のマイクロカプセル液(表2に記載) 表2記載の量 ただし、ゼラチン量は1.2g/m2になるように調整
した。Potassium tetrachloropalladium (2) 100 mg / m 2 Compound (G) 0.5 mg / m 2 2,6-bis (hydroxyamino) -4-diethylamino-1,3,5-triazine 5 mg / m 2 t-butyl-catechol 130 mg / m 2 polyvinylpyrrolidone (molecular weight 10,000) 35 mg / m 2 sodium polystyrene sulfonate 80 mg / m 2 trimethylolpropane 50 mg / m 2 diethylene glycol 50 mg / m 2 nitrophenyl-triphenyl-phosphonium chloride 20 mg / m 2 1,3 ammonium dihydroxybenzene-4-sulfonic acid 100 mg / m 2 2-mercaptobenzimidazole-5-sulfonate sodium 5 mg / m 2 compound (H) 0.5mg / m 2 n -C 4 H 9 OCH 2 CH (OH) CH 2 N (CH 2 COOH) 2 35 mg / m 2 Compound (M) 5 mg / m 2 Compound (N) 5 mg / m 2 Colloidal silica (mean particle size 0.014 μm) 500 mg / m 2 Latex (L) 500 mg / m 2 Dextran (average molecular weight 40,000) 100 mg / m 2 Microcapsule solution of the present invention (described in Table 2) Amount described in Table 2 However, the amount of gelatin was adjusted to be 1.2 g / m 2 .
【0134】 第3層(保護下層) ゼラチン 0.25g/m2 本発明のマイクロカプセル液(表2に記載) 表2記載の量 ポリアクリル酸ナトリウム(平均分子量500000) 30mg/m2 化合物(K) 15mg/m2 第4層(保護上層) ゼラチン 0.2g/m2 4−ヒドロキシ−6−メチル−1,3,3a,7−テト ラザインデン 50mg/m2 ポリメチルメタクリレート粒子(平均粒径4.0μm) 20mg/m2 ポリメチルメタクリレート粒子(平均粒径1.0μm) 50mg/m2 ホルムアルデヒド 20mg/m2 2,4−ジクロロ−6−ヒドロキシ−1,3,5−トリ アジンンナトウム塩 10mg/m2 ビス−ビニルスルホニルメチルエーテル 36mg/m2 ポリアクリルアミド(平均分子量10000) 50mg/m2 ポリシロキサン(SI) 20mg/m2 化合物(I) 12mg/m2 化合物(J) 2mg/m2 化合物(S−1) 7mg/m2 化合物(O) 50mg/m2 化合物(S−2) 5mg/m2 化合物(F−1) 3mg/m2 化合物(F−2) 2mg/m2 化合物(F−3) 1mg/m2 Third layer (protective lower layer) Gelatin 0.25 g / m 2 Microcapsule solution of the present invention (described in Table 2) Amount shown in Table 2 Sodium polyacrylate (average molecular weight 500000) 30 mg / m 2 Compound (K 15 mg / m 2 Fourth layer (protective upper layer) Gelatin 0.2 g / m 2 4-Hydroxy-6-methyl-1,3,3a, 7-tetrazindene 50 mg / m 2 Polymethyl methacrylate particles (average particle size 4 2.0 μm) 20 mg / m 2 polymethyl methacrylate particles (average particle size 1.0 μm) 50 mg / m 2 formaldehyde 20 mg / m 2 2,4-dichloro-6-hydroxy-1,3,5-triazine sodium salt 10 mg / m 2 bis-vinylsulfonyl methyl ether 36 mg / m 2 polyacrylamide (average molecular weight 10,000) 50 mg / m 2 poly Siloxane (SI) 20 mg / m 2 Compound (I) 12 mg / m 2 Compound (J) 2 mg / m 2 Compound (S-1) 7 mg / m 2 Compound (O) 50 mg / m 2 Compound (S-2) 5 mg / m 2 compound (F-1) 3 mg / m 2 compound (F-2) 2 mg / m 2 compound (F-3) 1 mg / m 2
【0135】[0135]
【化22】 Embedded image
【0136】[0136]
【化23】 Embedded image
【0137】[0137]
【化24】 Embedded image
【0138】なお、素材の付量は片面分であり、塗布銀
量は片面分として1.5g/m2になるように調整し
た。The amount of the material applied was one side, and the amount of silver applied was adjusted to 1.5 g / m 2 as one side.
【0139】上記により作成した試料を用い、銀色調、
カブリの評価を下記の要領で行った。Using the sample prepared as described above, silver tone,
Fog was evaluated in the following manner.
【0140】(1)銀色調の評価 試料の大角サイズ(35.6cm×35.6cm)を濃
度が1.2になるように均一にX線露光し、下記処理
を行った。この現像済試料を、シャーカステンで観察
し、透過光による銀色調を、目視により以下に示すラン
クで評価した。(1) Evaluation of Silver Tone A large-sized sample (35.6 cm × 35.6 cm) was uniformly exposed to X-rays so that the concentration became 1.2, and the following treatment was performed. The developed sample was observed with a Schaukasten, and the silver tone due to transmitted light was visually evaluated according to the following ranks.
【0141】 4:青味をおびた純黒色 3:やや青味をおびた黒色 2:やや黄色味をおびた黒色 1:黄色味をおびた黒色 《処理》 <自動現像機>SRX−501(コニカ(株)製)を改
造して搬送スピードを下記の様に速めたもの。4: Pure black with a blue tint 3: Black with a slight blue tint 2: Black with a slight yellow tint 1: Black with a yellow tint << Process >><Automatic developing machine> SRX-501 ( (Konica Co., Ltd.) was modified to increase the transport speed as follows.
【0142】<処理条件> 現像液処方 Part−A(12l仕上げ用) 水酸化カリウム 450g 亜硫酸カリウム(50%溶液) 2280g ジエチレンテトラアミン5酢酸 120g 重炭酸水素ナトリウム 132g 5−メチルベンゾトリアゾール 1.2g 1−フェニル−5−メルカプトテトラゾール 0.2g ハイドロキノン 340g 水を加えて 5000mlに仕上げる。<Processing conditions> Developing solution formulation Part-A (for finishing 12 L) Potassium hydroxide 450 g Potassium sulfite (50% solution) 2280 g Diethylenetetraamine pentaacetic acid 120 g Sodium bicarbonate 132 g 5-Methylbenzotriazole 1.2 g 1-Phenyl-5-mercaptotetrazole 0.2 g Hydroquinone 340 g Add water to make 5000 ml.
【0143】 Part−B(12l仕上げ用) 氷酢酸 170g トリエチレングリコール 185g 1−フェニル−3−ピラゾリドン 22g 5−ニトロインダゾール 0.4g スターター 氷酢酸 120g 臭化カリウム 225g 水を加えて 1.0lに仕上げる。Part-B (for finishing 12 L) Glacial acetic acid 170 g Triethylene glycol 185 g 1-Phenyl-3-pyrazolidone 22 g 5-Nitroindazole 0.4 g Starter Glacial acetic acid 120 g Potassium bromide 225 g Add water to make 1.0 L .
【0144】 定着液処方 Part−A(18l仕上げ用) チオ硫酸アンモニウム(70wt/vol%) 6000g 亜硫酸ナトリウム 110g 酢酸ナトリウム・3水塩 450g クエン酸ナトリウム 50g グルコン酸 70g 1−(N,N−ジメチルアミノ)−エチル−5−メルカプ トテトラゾール 18g Part−B 硫酸アルミニウム 800g 現像液の調製は水約5lにPartA、PartBを同
時添加し、撹拌溶解しながら水を加え12lに仕上げ氷
酢酸でpHを10.40に調整した。これを現像補充液
とする。Fixer Formulation Part-A (for 18 liter finishing) Ammonium thiosulfate (70 wt / vol%) 6000 g sodium sulfite 110 g sodium acetate trihydrate 450 g sodium citrate 50 g gluconic acid 70 g 1- (N, N-dimethylamino) -Ethyl-5-mercaptotetrazole 18 g Part-B 800 g of aluminum sulfate To prepare a developer, add Part A and Part B simultaneously to about 5 l of water, add water while stirring and dissolving, and add 12 l to finish. Was adjusted. This is used as a development replenisher.
【0145】この現像補充液1lに対して前記のスター
ターを20ml/l添加しpHを10.26に調整し使
用液とする。The starter described above was added to 1 liter of the development replenisher at 20 ml / l to adjust the pH to 10.26 to prepare a working solution.
【0146】定着液の調製は水約5lにPartA、P
artBを同時添加し、撹拌溶解しながら水を加え18
lに仕上げ、硫酸とNaOHを用いてpHを4.4に調
整した。これを定着補充液とする。The fixing solution was prepared by adding Part A, P
artB was added at the same time, and water was added while stirring and dissolving.
and the pH was adjusted to 4.4 using sulfuric acid and NaOH. This is used as a fixing replenisher.
【0147】(2)未露光部での青色濃度上昇の評価 温度23℃、相対湿度50%の条件(A)と、温度55
℃、相対湿度50%の条件(B)の下で各試料を5日間
保存した後に、未露光のまま上記処理条件で現像処理を
行った。各試料の分光吸収スペクトルを測定し、条件
(B)保存の試料の600nmの値から条件(A)保存
の試料の600nmの値を差し引いてΔAbsとした。(2) Evaluation of Blue Density Increase in Unexposed Area Condition (A) at a temperature of 23 ° C. and a relative humidity of 50%;
After storing each sample for 5 days under the condition (B) of 50 ° C. and a relative humidity of 50%, development processing was performed under the above processing conditions without exposure. The spectral absorption spectrum of each sample was measured, and the value at 600 nm of the sample stored under the condition (A) was subtracted from the value at 600 nm of the sample stored under the condition (B) to obtain ΔAbs.
【0148】(3)カブリの評価 温度23℃、相対湿度50%の条件(A)と、温度55
℃、相対湿度50%の条件(B)の下で各試料を5日間
保存した後に、未露光のまま上記処理条件で現像処理を
行った。各試料の濃度を測定し、条件(B)保存の試料
の値から条件(A)保存の試料の値を差し引いてΔカブ
リとした。(3) Evaluation of fog Condition (A) at a temperature of 23 ° C. and a relative humidity of 50%, and a temperature of 55
After storing each sample for 5 days under the condition (B) of 50 ° C. and a relative humidity of 50%, development processing was performed under the above processing conditions without exposure. The concentration of each sample was measured, and the value of the sample stored under the condition (A) was subtracted from the value of the sample stored under the condition (B) to obtain Δfog.
【0149】これらの結果を表2に示す。Table 2 shows the results.
【0150】[0150]
【表2】 [Table 2]
【0151】表2から明らかなように、本発明の試料
は、銀色調が良好で、かつ安定性に優れたハロゲン化銀
写真感光材料であることがわかる。As is clear from Table 2, the sample of the present invention is a silver halide photographic material having a good silver tone and excellent stability.
【0152】[0152]
【発明の効果】本発明により、安定性、保存性に優れた
ハロゲン化銀写真感光材料を提供することができた。According to the present invention, a silver halide photographic material excellent in stability and storage stability can be provided.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 千葉 隆人 東京都日野市さくら町1番地コニカ株式会 社内 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Takato Chiba Konica Corporation, 1 Sakuracho, Hino City, Tokyo
Claims (4)
化銀乳剤層を含む親水性コロイド層を設けたハロゲン化
銀写真感光材料において、前記親水性コロイド層が、ポ
リマーによってマイクロカプセル化した写真有用化合物
を含有することを特徴とするハロゲン化銀写真感光材
料。1. A silver halide photographic material comprising a support and a hydrophilic colloid layer comprising at least one silver halide emulsion layer, wherein the hydrophilic colloid layer is microencapsulated with a polymer. A silver halide photographic light-sensitive material comprising a useful compound.
マーであることを特徴とする請求項1記載のハロゲン化
銀写真感光材料。2. The silver halide photographic material according to claim 1, wherein the polymer is an alkali-soluble polymer.
あることを特徴とする請求項1または2記載のハロゲン
化銀写真感光材料。3. The silver halide photographic material according to claim 1, wherein the polymer is soluble at pH = 6 or more.
体と反応して青色色素を形成するロイコ化合物であるこ
とを特徴とする請求項1〜3のいずれか1項記載のハロ
ゲン化銀写真感光材料。4. The silver halide photograph according to claim 1, wherein the photographically useful compound is a leuco compound which forms a blue dye by reacting with an oxidized form of a developing agent. Photosensitive material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17828297A JPH1124193A (en) | 1997-07-03 | 1997-07-03 | Silver halide photographic sensitive material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17828297A JPH1124193A (en) | 1997-07-03 | 1997-07-03 | Silver halide photographic sensitive material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1124193A true JPH1124193A (en) | 1999-01-29 |
Family
ID=16045752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17828297A Pending JPH1124193A (en) | 1997-07-03 | 1997-07-03 | Silver halide photographic sensitive material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1124193A (en) |
-
1997
- 1997-07-03 JP JP17828297A patent/JPH1124193A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS589411B2 (en) | High contrast photographic material | |
| JPH0643583A (en) | Silver halide photographic sensitive material | |
| US4521508A (en) | Silver halide photographic light-sensitive materials | |
| JP3041734B2 (en) | Silver halide photographic material | |
| JP3124663B2 (en) | Silver halide photographic materials | |
| JP2791492B2 (en) | Image forming method | |
| JP3817787B2 (en) | Leuco dye, silver halide photographic material, image forming method thereof and processing method thereof | |
| JPH1124193A (en) | Silver halide photographic sensitive material | |
| JP2849864B2 (en) | Silver halide photographic material and processing method thereof | |
| JP3467658B2 (en) | Silver halide photographic light-sensitive material and its development processing method | |
| JPS62148942A (en) | Silver halide photographic sensitive material | |
| JP3545680B2 (en) | Solid fine particle dispersion of dye | |
| US5240826A (en) | Silver halide photographic light-sensitive materials | |
| JPH06138575A (en) | Silver halide photographic sensitive material | |
| JP2764352B2 (en) | Silver halide photographic material | |
| JPH10319532A (en) | Silver halide photographic sensitive material | |
| JPH10123657A (en) | Processing method of silver halide photographic material | |
| JPH11143014A (en) | Dispersion of leuco compound and silver halide photographic sensitive material using same | |
| JPH0338635A (en) | Silver halide photographic sensitive material | |
| JPH075629A (en) | Silver halide photographic sensitive material | |
| JPH115916A (en) | Arylidene compound and silver halide photographic material | |
| JPH0419645A (en) | Silver halide photographic sensitive material | |
| JPH0693087B2 (en) | Method for producing silver halide photographic light-sensitive material | |
| JPH04166835A (en) | Developing method for silver halogenide photosensitive material | |
| JPH08146549A (en) | Silver halide compound photographic emulsion and sensitive material |